Idx,Title,node-A,edge,edge_normalized,node-B
140, Genistein Ameliorates Renal Fibrosis Through Regulation Snail via m6A RNA Demethylase ALKBH5. Genistein,Genistein,Ameliorates,TREATS,Renal Fibrosis
140, Genistein Ameliorates Renal Fibrosis Through Regulation Snail via m6A RNA Demethylase ALKBH5. Genistein,Genistein,Ameliorates,TREATS,Fibrosis
215, Total Flavones of Abelmoschus manihot Ameliorates Podocyte Pyroptosis and Injury in High Glucose Conditions by Targeting METTL3-Dependent m6A Modification-Mediated NLRP3-Inflammasome Activation and PTEN/PI3K/Akt Signaling. Flavones,Flavones,Ameliorates,TREATS,Podocyte Pyroptosis
215, Total Flavones of Abelmoschus manihot Ameliorates Podocyte Pyroptosis and Injury in High Glucose Conditions by Targeting METTL3-Dependent m6A Modification-Mediated NLRP3-Inflammasome Activation and PTEN/PI3K/Akt Signaling. Total Flavones,Total Flavones,Ameliorates,TREATS,Podocyte Pyroptosis
414, M6A-mediated upregulation of HOXC10 promotes human hepatocellular carcinoma development through PTEN/AKT/mTOR signaling pathway human carcinoma development,human carcinoma development,upregulation of,STIMULATES,HOXC10
414, M6A-mediated upregulation of HOXC10 promotes human hepatocellular carcinoma development through PTEN/AKT/mTOR signaling pathway carcinoma development,carcinoma development,upregulation of,STIMULATES,HOXC10
414, M6A-mediated upregulation of HOXC10 promotes human hepatocellular carcinoma development through PTEN/AKT/mTOR signaling pathway hepatocellular carcinoma development,hepatocellular carcinoma development,upregulation of,STIMULATES,HOXC10
414, M6A-mediated upregulation of HOXC10 promotes human hepatocellular carcinoma development through PTEN/AKT/mTOR signaling pathway human hepatocellular carcinoma development,human hepatocellular carcinoma development,upregulation of,STIMULATES,HOXC10
429, M6A-mediated-upregulation of lncRNA BLACAT3 promotes bladder cancer angiogenesis and hematogenous metastasis through YBX3 nuclear shuttling and enhancing NCF2 transcription. bladder cancer angiogenesis,bladder cancer angiogenesis,upregulation of,STIMULATES,lncRNA BLACAT3
398," ""m6A-dependent upregulation of DRG1 by METTL3 and ELAVL1 promotes growth, migration, and colony formation in osteosarcoma."" growth",growth,upregulation of,STIMULATES,DRG1
249, N6-methyladenosine-mediated upregulation of WTAPP1 promotes WTAP translation and Wnt signaling to facilitate pancreatic cancer progression. WTAP translation,WTAP translation,upregulation of,STIMULATES,WTAPP1
398," ""m6A-dependent upregulation of DRG1 by METTL3 and ELAVL1 promotes growth, migration, and colony formation in osteosarcoma."" growth",growth,upregulation by,STIMULATES,METTL3
429, M6A-mediated-upregulation of lncRNA BLACAT3 promotes bladder cancer angiogenesis and hematogenous metastasis through YBX3 nuclear shuttling and enhancing NCF2 transcription. bladder cancer angiogenesis,bladder cancer angiogenesis,upregulation,STIMULATES,hematogenous metastasis
429, M6A-mediated-upregulation of lncRNA BLACAT3 promotes bladder cancer angiogenesis and hematogenous metastasis through YBX3 nuclear shuttling and enhancing NCF2 transcription. bladder cancer angiogenesis,bladder cancer angiogenesis,upregulation,STIMULATES,metastasis
398," ""m6A-dependent upregulation of DRG1 by METTL3 and ELAVL1 promotes growth, migration, and colony formation in osteosarcoma."" growth",growth,upregulation,STIMULATES,colony formation
398," ""m6A-dependent upregulation of DRG1 by METTL3 and ELAVL1 promotes growth, migration, and colony formation in osteosarcoma."" growth",growth,upregulation,STIMULATES,migration
15, AMD1 upregulates hepatocellular carcinoma cells stemness by FTO mediated mRNA demethylation. AMD1,AMD1,upregulates carcinoma cells stemness by,N/A,mediated mRNA demethylation
15, AMD1 upregulates hepatocellular carcinoma cells stemness by FTO mediated mRNA demethylation. AMD1,AMD1,upregulates carcinoma cells stemness by,N/A,mRNA demethylation
359, Upregulated METTL3 in nasopharyngeal carcinoma enhances the motility of cancer cells. motility,motility,Upregulated METTL3 in,N/A,nasopharyngeal carcinoma
359, Upregulated METTL3 in nasopharyngeal carcinoma enhances the motility of cancer cells. motility,motility,Upregulated METTL3 in,N/A,carcinoma
395," ""CircMETTL3, upregulated in a m6A-dependent manner, promotes breast cancer progression."" CircMETTL3",CircMETTL3,upregulated in,N/A,m6A dependent manner
395," ""CircMETTL3, upregulated in a m6A-dependent manner, promotes breast cancer progression."" CircMETTL3",CircMETTL3,upregulated in,N/A,manner
426, METTL3 Promotes the Growth and Invasion of Melanoma Cells by Regulating the lncRNA SNHG3/miR-330-5p Axis. METTL3,METTL3,Promotes,STIMULATES,Growth of Melanoma Cells
426, METTL3 Promotes the Growth and Invasion of Melanoma Cells by Regulating the lncRNA SNHG3/miR-330-5p Axis. METTL3,METTL3,Promotes,STIMULATES,Growth
2, METTL14 Overexpression Promotes Osteosarcoma Cell Apoptosis and Slows Tumor Progression via Caspase 3 Activation. METTL14 Overexpression,METTL14 Overexpression,Promotes,STIMULATES,Osteosarcoma Cell Apoptosis
3, Downregulation of m6A Reader YTHDC2 Promotes the Proliferation and Migration of Malignant Lung Cells via CYLD/NF-kappaB Pathway. Downregulation,Downregulation,Promotes,STIMULATES,Proliferation
3, Downregulation of m6A Reader YTHDC2 Promotes the Proliferation and Migration of Malignant Lung Cells via CYLD/NF-kappaB Pathway. Downregulation,Downregulation,Promotes,STIMULATES,Proliferation of Lung Cells
3, Downregulation of m6A Reader YTHDC2 Promotes the Proliferation and Migration of Malignant Lung Cells via CYLD/NF-kappaB Pathway. Downregulation,Downregulation,Promotes,STIMULATES,Proliferation of Malignant Lung Cells
18, METTL3 Promotes Esophageal Squamous Cell Carcinoma Metastasis Through Enhancing GLS2 Expression. METTL3,METTL3,Promotes,STIMULATES,Esophageal Squamous Cell Carcinoma Metastasis
18, METTL3 Promotes Esophageal Squamous Cell Carcinoma Metastasis Through Enhancing GLS2 Expression. METTL3,METTL3,Promotes,STIMULATES,Esophageal Cell Carcinoma Metastasis
18, METTL3 Promotes Esophageal Squamous Cell Carcinoma Metastasis Through Enhancing GLS2 Expression. METTL3,METTL3,Promotes,STIMULATES,Squamous Cell Carcinoma Metastasis
18, METTL3 Promotes Esophageal Squamous Cell Carcinoma Metastasis Through Enhancing GLS2 Expression. METTL3,METTL3,Promotes,STIMULATES,Cell Carcinoma Metastasis
30, Reduced Expression of METTL3 Promotes Metastasis of Triple-Negative Breast Cancer by m6A Methylation-Mediated COL3A1 Up-Regulation. Expression,Expression,Promotes,STIMULATES,Metastasis of Breast Cancer
30, Reduced Expression of METTL3 Promotes Metastasis of Triple-Negative Breast Cancer by m6A Methylation-Mediated COL3A1 Up-Regulation. Reduced Expression,Reduced Expression,Promotes,STIMULATES,Metastasis of Triple Negative Breast Cancer
30, Reduced Expression of METTL3 Promotes Metastasis of Triple-Negative Breast Cancer by m6A Methylation-Mediated COL3A1 Up-Regulation. Reduced Expression,Reduced Expression,Promotes,STIMULATES,Metastasis of Breast Cancer
30, Reduced Expression of METTL3 Promotes Metastasis of Triple-Negative Breast Cancer by m6A Methylation-Mediated COL3A1 Up-Regulation. Expression,Expression,Promotes,STIMULATES,Metastasis of Triple Negative Breast Cancer
30, Reduced Expression of METTL3 Promotes Metastasis of Triple-Negative Breast Cancer by m6A Methylation-Mediated COL3A1 Up-Regulation. Reduced Expression,Reduced Expression,Promotes,STIMULATES,Metastasis
30, Reduced Expression of METTL3 Promotes Metastasis of Triple-Negative Breast Cancer by m6A Methylation-Mediated COL3A1 Up-Regulation. Expression,Expression,Promotes,STIMULATES,Metastasis
32, METTL3 Promotes the Resistance of Glioma to Temozolomide via Increasing MGMT and ANPG in a m6A Dependent Manner. METTL3,METTL3,Promotes,STIMULATES,Resistance
32, METTL3 Promotes the Resistance of Glioma to Temozolomide via Increasing MGMT and ANPG in a m6A Dependent Manner. METTL3,METTL3,Promotes,STIMULATES,Resistance of Glioma
32, METTL3 Promotes the Resistance of Glioma to Temozolomide via Increasing MGMT and ANPG in a m6A Dependent Manner. METTL3,METTL3,Promotes,STIMULATES,Resistance to Temozolomide
32, METTL3 Promotes the Resistance of Glioma to Temozolomide via Increasing MGMT and ANPG in a m6A Dependent Manner. METTL3,METTL3,Promotes,STIMULATES,Resistance of Glioma to Temozolomide
99, RNA m6A Methyltransferase METTL3 Promotes The Growth Of Prostate Cancer By Regulating Hedgehog Pathway. RNA m6A Methyltransferase METTL3,RNA m6A Methyltransferase METTL3,Promotes,STIMULATES,Growth Of Prostate Cancer
99, RNA m6A Methyltransferase METTL3 Promotes The Growth Of Prostate Cancer By Regulating Hedgehog Pathway. RNA m6A Methyltransferase METTL3,RNA m6A Methyltransferase METTL3,Promotes,STIMULATES,Growth
101, Hypoxia Promotes Vascular Smooth Muscle Cell (VSMC) Differentiation of Adipose-Derived Stem Cell (ADSC) by Regulating Mettl3 and Paracrine Factors. Hypoxia,Hypoxia,Promotes,STIMULATES,VSMC Differentiation
101, Hypoxia Promotes Vascular Smooth Muscle Cell (VSMC) Differentiation of Adipose-Derived Stem Cell (ADSC) by Regulating Mettl3 and Paracrine Factors. Hypoxia,Hypoxia,Promotes,STIMULATES,VSMC Differentiation of Stem Cell
101, Hypoxia Promotes Vascular Smooth Muscle Cell (VSMC) Differentiation of Adipose-Derived Stem Cell (ADSC) by Regulating Mettl3 and Paracrine Factors. Hypoxia,Hypoxia,Promotes,STIMULATES,VSMC Differentiation of Derived Stem Cell
101, Hypoxia Promotes Vascular Smooth Muscle Cell (VSMC) Differentiation of Adipose-Derived Stem Cell (ADSC) by Regulating Mettl3 and Paracrine Factors. Hypoxia,Hypoxia,Promotes,STIMULATES,VSMC Differentiation of Adipose Derived Stem Cell
103, METTL3 Promotes the Progression of Gastric Cancer via Targeting the MYC Pathway. METTL3,METTL3,Promotes,STIMULATES,Progression of Cancer
103, METTL3 Promotes the Progression of Gastric Cancer via Targeting the MYC Pathway. METTL3,METTL3,Promotes,STIMULATES,Progression
103, METTL3 Promotes the Progression of Gastric Cancer via Targeting the MYC Pathway. METTL3,METTL3,Promotes,STIMULATES,Progression of Gastric Cancer
146, METTL3 Promotes Tumorigenesis and Metastasis through BMI1 m6A Methylation in Oral Squamous Cell Carcinoma. METTL3,METTL3,Promotes,STIMULATES,Tumorigenesis
163, ALKBH5 Promotes the Proliferation of Glioma Cells via Enhancing the mRNA Stability of G6PD. ALKBH5,ALKBH5,Promotes,STIMULATES,Proliferation
163, ALKBH5 Promotes the Proliferation of Glioma Cells via Enhancing the mRNA Stability of G6PD. ALKBH5,ALKBH5,Promotes,STIMULATES,Proliferation of Glioma Cells
173, N6-Methyladenosine RNA Demethylase FTO Promotes Gastric Cancer Metastasis by Down-Regulating the m6A Methylation of ITGB1. N6 Methyladenosine RNA Demethylase FTO,N6 Methyladenosine RNA Demethylase FTO,Promotes,STIMULATES,Cancer Metastasis
173, N6-Methyladenosine RNA Demethylase FTO Promotes Gastric Cancer Metastasis by Down-Regulating the m6A Methylation of ITGB1. N6 Methyladenosine RNA Demethylase FTO,N6 Methyladenosine RNA Demethylase FTO,Promotes,STIMULATES,Gastric Cancer Metastasis
177, Vascular Smooth Muscle FTO Promotes Aortic Dissecting Aneurysms via m6A Modification of Klf5. Muscle FTO,Muscle FTO,Promotes,STIMULATES,Aortic Aneurysms
177, Vascular Smooth Muscle FTO Promotes Aortic Dissecting Aneurysms via m6A Modification of Klf5. Vascular Muscle FTO,Vascular Muscle FTO,Promotes,STIMULATES,Aortic Dissecting Aneurysms
177, Vascular Smooth Muscle FTO Promotes Aortic Dissecting Aneurysms via m6A Modification of Klf5. Muscle FTO,Muscle FTO,Promotes,STIMULATES,Dissecting Aneurysms
177, Vascular Smooth Muscle FTO Promotes Aortic Dissecting Aneurysms via m6A Modification of Klf5. Vascular Smooth Muscle FTO,Vascular Smooth Muscle FTO,Promotes,STIMULATES,Aneurysms
177, Vascular Smooth Muscle FTO Promotes Aortic Dissecting Aneurysms via m6A Modification of Klf5. Smooth Muscle FTO,Smooth Muscle FTO,Promotes,STIMULATES,Dissecting Aneurysms
177, Vascular Smooth Muscle FTO Promotes Aortic Dissecting Aneurysms via m6A Modification of Klf5. Vascular Smooth Muscle FTO,Vascular Smooth Muscle FTO,Promotes,STIMULATES,Aortic Dissecting Aneurysms
177, Vascular Smooth Muscle FTO Promotes Aortic Dissecting Aneurysms via m6A Modification of Klf5. Vascular Muscle FTO,Vascular Muscle FTO,Promotes,STIMULATES,Aneurysms
177, Vascular Smooth Muscle FTO Promotes Aortic Dissecting Aneurysms via m6A Modification of Klf5. Smooth Muscle FTO,Smooth Muscle FTO,Promotes,STIMULATES,Aortic Dissecting Aneurysms
177, Vascular Smooth Muscle FTO Promotes Aortic Dissecting Aneurysms via m6A Modification of Klf5. Muscle FTO,Muscle FTO,Promotes,STIMULATES,Aortic Dissecting Aneurysms
177, Vascular Smooth Muscle FTO Promotes Aortic Dissecting Aneurysms via m6A Modification of Klf5. Muscle FTO,Muscle FTO,Promotes,STIMULATES,Aneurysms
177, Vascular Smooth Muscle FTO Promotes Aortic Dissecting Aneurysms via m6A Modification of Klf5. Vascular Smooth Muscle FTO,Vascular Smooth Muscle FTO,Promotes,STIMULATES,Aortic Aneurysms
177, Vascular Smooth Muscle FTO Promotes Aortic Dissecting Aneurysms via m6A Modification of Klf5. Smooth Muscle FTO,Smooth Muscle FTO,Promotes,STIMULATES,Aortic Aneurysms
177, Vascular Smooth Muscle FTO Promotes Aortic Dissecting Aneurysms via m6A Modification of Klf5. Vascular Smooth Muscle FTO,Vascular Smooth Muscle FTO,Promotes,STIMULATES,Dissecting Aneurysms
177, Vascular Smooth Muscle FTO Promotes Aortic Dissecting Aneurysms via m6A Modification of Klf5. Vascular Muscle FTO,Vascular Muscle FTO,Promotes,STIMULATES,Dissecting Aneurysms
177, Vascular Smooth Muscle FTO Promotes Aortic Dissecting Aneurysms via m6A Modification of Klf5. Vascular Muscle FTO,Vascular Muscle FTO,Promotes,STIMULATES,Aortic Aneurysms
177, Vascular Smooth Muscle FTO Promotes Aortic Dissecting Aneurysms via m6A Modification of Klf5. Smooth Muscle FTO,Smooth Muscle FTO,Promotes,STIMULATES,Aneurysms
186, YTHDF1 Promotes Cyclin B1 Translation through m6A Modulation and Contributes to the Poor Prognosis of Lung Adenocarcinoma with KRAS/TP53 Co-Mutation. YTHDF1,YTHDF1,Promotes,STIMULATES,Cyclin B1 Translation
326, The m6A RNA Demethylase ALKBH5 Promotes Radioresistance and Invasion Capability of Glioma Stem Cells. m6A RNA Demethylase ALKBH5,m6A RNA Demethylase ALKBH5,Promotes,STIMULATES,Radioresistance
326, The m6A RNA Demethylase ALKBH5 Promotes Radioresistance and Invasion Capability of Glioma Stem Cells. m6A RNA Demethylase ALKBH5,m6A RNA Demethylase ALKBH5,Promotes,STIMULATES,Radioresistance of Glioma Stem Cells
240, METTL3-Induced miR-222-3p Upregulation Inhibits STK4 and Promotes the Malignant Behaviors of Thyroid Carcinoma Cells. Induced miR -222-3p Upregulation,Induced miR -222-3p Upregulation,Promotes,STIMULATES,Malignant Behaviors
240, METTL3-Induced miR-222-3p Upregulation Inhibits STK4 and Promotes the Malignant Behaviors of Thyroid Carcinoma Cells. Induced miR -222-3p Upregulation,Induced miR -222-3p Upregulation,Promotes,STIMULATES,Malignant Behaviors of Thyroid Carcinoma Cells
240, METTL3-Induced miR-222-3p Upregulation Inhibits STK4 and Promotes the Malignant Behaviors of Thyroid Carcinoma Cells. Induced miR -222-3p Upregulation,Induced miR -222-3p Upregulation,Promotes,STIMULATES,Behaviors of Thyroid Carcinoma Cells
240, METTL3-Induced miR-222-3p Upregulation Inhibits STK4 and Promotes the Malignant Behaviors of Thyroid Carcinoma Cells. Induced miR -222-3p Upregulation,Induced miR -222-3p Upregulation,Promotes,STIMULATES,Behaviors
265, m6A Reader YTHDC2 Promotes Radiotherapy Resistance of Nasopharyngeal Carcinoma via Activating IGF1R/AKT/S6 Signaling Axis. m6A Reader YTHDC2,m6A Reader YTHDC2,Promotes,STIMULATES,Radiotherapy Resistance of Nasopharyngeal Carcinoma
265, m6A Reader YTHDC2 Promotes Radiotherapy Resistance of Nasopharyngeal Carcinoma via Activating IGF1R/AKT/S6 Signaling Axis. m6A Reader YTHDC2,m6A Reader YTHDC2,Promotes,STIMULATES,Radiotherapy Resistance
275, METTL14 Inhibits Hematopoietic Stem/Progenitor Differentiation and Promotes Leukemogenesis via mRNA m6A Modification. METTL14,METTL14,Promotes,STIMULATES,Leukemogenesis
314, Ribosome 18S m6A Methyltransferase METTL5 Promotes Translation Initiation and Breast Cancer Cell Growth. Ribosome 18S m6A Methyltransferase METTL5,Ribosome 18S m6A Methyltransferase METTL5,Promotes,STIMULATES,Translation Initiation
243, Tumor-Associated Macrophages Promote Oxaliplatin Resistance via METTL3-Mediated m6A of TRAF5 and Necroptosis in Colorectal Cancer. Associated Macrophages,Associated Macrophages,Promote,STIMULATES,Oxaliplatin Resistance
259, METTL3 and N6-Methyladenosine Promote Homologous Recombination-Mediated Repair of DSBs by Modulating DNA-RNA Hybrid Accumulation. N6 Methyladenosine,N6 Methyladenosine,Promote,STIMULATES,Homologous Recombination Mediated Repair of DSBs
259, METTL3 and N6-Methyladenosine Promote Homologous Recombination-Mediated Repair of DSBs by Modulating DNA-RNA Hybrid Accumulation. METTL3,METTL3,Promote,STIMULATES,Repair of DSBs
259, METTL3 and N6-Methyladenosine Promote Homologous Recombination-Mediated Repair of DSBs by Modulating DNA-RNA Hybrid Accumulation. METTL3,METTL3,Promote,STIMULATES,Homologous Repair
259, METTL3 and N6-Methyladenosine Promote Homologous Recombination-Mediated Repair of DSBs by Modulating DNA-RNA Hybrid Accumulation. METTL3,METTL3,Promote,STIMULATES,Mediated Repair of DSBs
259, METTL3 and N6-Methyladenosine Promote Homologous Recombination-Mediated Repair of DSBs by Modulating DNA-RNA Hybrid Accumulation. METTL3,METTL3,Promote,STIMULATES,Recombination Mediated Repair of DSBs
259, METTL3 and N6-Methyladenosine Promote Homologous Recombination-Mediated Repair of DSBs by Modulating DNA-RNA Hybrid Accumulation. N6 Methyladenosine,N6 Methyladenosine,Promote,STIMULATES,Mediated Repair
259, METTL3 and N6-Methyladenosine Promote Homologous Recombination-Mediated Repair of DSBs by Modulating DNA-RNA Hybrid Accumulation. N6 Methyladenosine,N6 Methyladenosine,Promote,STIMULATES,Repair
259, METTL3 and N6-Methyladenosine Promote Homologous Recombination-Mediated Repair of DSBs by Modulating DNA-RNA Hybrid Accumulation. METTL3,METTL3,Promote,STIMULATES,Homologous Repair of DSBs
259, METTL3 and N6-Methyladenosine Promote Homologous Recombination-Mediated Repair of DSBs by Modulating DNA-RNA Hybrid Accumulation. N6 Methyladenosine,N6 Methyladenosine,Promote,STIMULATES,Homologous Mediated Repair
259, METTL3 and N6-Methyladenosine Promote Homologous Recombination-Mediated Repair of DSBs by Modulating DNA-RNA Hybrid Accumulation. METTL3,METTL3,Promote,STIMULATES,Homologous Recombination Mediated Repair
259, METTL3 and N6-Methyladenosine Promote Homologous Recombination-Mediated Repair of DSBs by Modulating DNA-RNA Hybrid Accumulation. N6 Methyladenosine,N6 Methyladenosine,Promote,STIMULATES,Recombination Mediated Repair
259, METTL3 and N6-Methyladenosine Promote Homologous Recombination-Mediated Repair of DSBs by Modulating DNA-RNA Hybrid Accumulation. METTL3,METTL3,Promote,STIMULATES,Mediated Repair
259, METTL3 and N6-Methyladenosine Promote Homologous Recombination-Mediated Repair of DSBs by Modulating DNA-RNA Hybrid Accumulation. N6 Methyladenosine,N6 Methyladenosine,Promote,STIMULATES,Homologous Repair
259, METTL3 and N6-Methyladenosine Promote Homologous Recombination-Mediated Repair of DSBs by Modulating DNA-RNA Hybrid Accumulation. N6 Methyladenosine,N6 Methyladenosine,Promote,STIMULATES,Mediated Repair of DSBs
259, METTL3 and N6-Methyladenosine Promote Homologous Recombination-Mediated Repair of DSBs by Modulating DNA-RNA Hybrid Accumulation. N6 Methyladenosine,N6 Methyladenosine,Promote,STIMULATES,Homologous Repair of DSBs
259, METTL3 and N6-Methyladenosine Promote Homologous Recombination-Mediated Repair of DSBs by Modulating DNA-RNA Hybrid Accumulation. METTL3,METTL3,Promote,STIMULATES,Repair
259, METTL3 and N6-Methyladenosine Promote Homologous Recombination-Mediated Repair of DSBs by Modulating DNA-RNA Hybrid Accumulation. METTL3,METTL3,Promote,STIMULATES,Homologous Mediated Repair of DSBs
259, METTL3 and N6-Methyladenosine Promote Homologous Recombination-Mediated Repair of DSBs by Modulating DNA-RNA Hybrid Accumulation. METTL3,METTL3,Promote,STIMULATES,Homologous Mediated Repair
259, METTL3 and N6-Methyladenosine Promote Homologous Recombination-Mediated Repair of DSBs by Modulating DNA-RNA Hybrid Accumulation. N6 Methyladenosine,N6 Methyladenosine,Promote,STIMULATES,Homologous Mediated Repair of DSBs
259, METTL3 and N6-Methyladenosine Promote Homologous Recombination-Mediated Repair of DSBs by Modulating DNA-RNA Hybrid Accumulation. N6 Methyladenosine,N6 Methyladenosine,Promote,STIMULATES,Recombination Mediated Repair of DSBs
259, METTL3 and N6-Methyladenosine Promote Homologous Recombination-Mediated Repair of DSBs by Modulating DNA-RNA Hybrid Accumulation. N6 Methyladenosine,N6 Methyladenosine,Promote,STIMULATES,Repair of DSBs
259, METTL3 and N6-Methyladenosine Promote Homologous Recombination-Mediated Repair of DSBs by Modulating DNA-RNA Hybrid Accumulation. N6 Methyladenosine,N6 Methyladenosine,Promote,STIMULATES,Homologous Recombination Mediated Repair
259, METTL3 and N6-Methyladenosine Promote Homologous Recombination-Mediated Repair of DSBs by Modulating DNA-RNA Hybrid Accumulation. METTL3,METTL3,Promote,STIMULATES,Homologous Recombination Mediated Repair of DSBs
259, METTL3 and N6-Methyladenosine Promote Homologous Recombination-Mediated Repair of DSBs by Modulating DNA-RNA Hybrid Accumulation. METTL3,METTL3,Promote,STIMULATES,Recombination Mediated Repair
224, METTL3 Intensifies the Progress of Oral Squamous Cell Carcinoma via Modulating the m6A Amount of PRMT5 and PD-L1. METTL3,METTL3,Intensifies,STIMULATES,Progress
224, METTL3 Intensifies the Progress of Oral Squamous Cell Carcinoma via Modulating the m6A Amount of PRMT5 and PD-L1. METTL3,METTL3,Intensifies,STIMULATES,Progress of Oral Squamous Cell Carcinoma
224, METTL3 Intensifies the Progress of Oral Squamous Cell Carcinoma via Modulating the m6A Amount of PRMT5 and PD-L1. METTL3,METTL3,Intensifies,STIMULATES,Progress of Cell Carcinoma
224, METTL3 Intensifies the Progress of Oral Squamous Cell Carcinoma via Modulating the m6A Amount of PRMT5 and PD-L1. METTL3,METTL3,Intensifies,STIMULATES,Progress of Oral Cell Carcinoma
224, METTL3 Intensifies the Progress of Oral Squamous Cell Carcinoma via Modulating the m6A Amount of PRMT5 and PD-L1. METTL3,METTL3,Intensifies,STIMULATES,Progress of Squamous Cell Carcinoma
162, YTHDF1 Facilitates the Progression of Hepatocellular Carcinoma by Promoting FZD5 mRNA Translation in an m6A-Dependent Manner. YTHDF1,YTHDF1,Facilitates Progression in,N/A,Manner
162, YTHDF1 Facilitates the Progression of Hepatocellular Carcinoma by Promoting FZD5 mRNA Translation in an m6A-Dependent Manner. YTHDF1,YTHDF1,Facilitates Progression in,N/A,m6A Dependent Manner
162, YTHDF1 Facilitates the Progression of Hepatocellular Carcinoma by Promoting FZD5 mRNA Translation in an m6A-Dependent Manner. YTHDF1,YTHDF1,Facilitates Progression by,N/A,Promoting FZD5 mRNA Translation
162, YTHDF1 Facilitates the Progression of Hepatocellular Carcinoma by Promoting FZD5 mRNA Translation in an m6A-Dependent Manner. YTHDF1,YTHDF1,Facilitates Progression by,N/A,FZD5 mRNA Translation
237, The N6-methyladenosine (m6A)-forming enzyme METTL3 facilitates M1 macrophage polarization through the methylation of STAT1 mRNA. enzyme METTL3,enzyme METTL3,facilitates M1 macrophage polarization through,N/A,methylation of STAT1 mRNA
237, The N6-methyladenosine (m6A)-forming enzyme METTL3 facilitates M1 macrophage polarization through the methylation of STAT1 mRNA. forming enzyme METTL3,forming enzyme METTL3,facilitates M1 macrophage polarization through,N/A,methylation
237, The N6-methyladenosine (m6A)-forming enzyme METTL3 facilitates M1 macrophage polarization through the methylation of STAT1 mRNA. enzyme METTL3,enzyme METTL3,facilitates M1 macrophage polarization through,N/A,methylation
237, The N6-methyladenosine (m6A)-forming enzyme METTL3 facilitates M1 macrophage polarization through the methylation of STAT1 mRNA. forming enzyme METTL3,forming enzyme METTL3,facilitates M1 macrophage polarization through,N/A,methylation of STAT1 mRNA
53, FTO Facilitates Lung Adenocarcinoma Cell Progression by Activating Cell Migration Through mRNA Demethylation. FTO,FTO,Facilitates Lung Adenocarcinoma Cell Progression Through,N/A,mRNA Demethylation
53, FTO Facilitates Lung Adenocarcinoma Cell Progression by Activating Cell Migration Through mRNA Demethylation. FTO,FTO,Facilitates Lung Adenocarcinoma Cell Progression by,N/A,Activating Cell Migration
53, FTO Facilitates Lung Adenocarcinoma Cell Progression by Activating Cell Migration Through mRNA Demethylation. FTO,FTO,Facilitates Lung Adenocarcinoma Cell Progression by,N/A,Cell Migration
252, m6A facilitates hippocampus-dependent learning and memory through YTHDF1. m6A,m6A,facilitates learning through,N/A,YTHDF1
34, METTL3 Facilitates Oral Squamous Cell Carcinoma Tumorigenesis by Enhancing c-Myc Stability via YTHDF1-Mediated m6A Modification. METTL3,METTL3,Facilitates Cell Carcinoma Tumorigenesis via,N/A,m6A Modification
34, METTL3 Facilitates Oral Squamous Cell Carcinoma Tumorigenesis by Enhancing c-Myc Stability via YTHDF1-Mediated m6A Modification. METTL3,METTL3,Facilitates Cell Carcinoma Tumorigenesis via,N/A,YTHDF1 Mediated m6A Modification
34, METTL3 Facilitates Oral Squamous Cell Carcinoma Tumorigenesis by Enhancing c-Myc Stability via YTHDF1-Mediated m6A Modification. METTL3,METTL3,Facilitates Cell Carcinoma Tumorigenesis via,N/A,Mediated m6A Modification
34, METTL3 Facilitates Oral Squamous Cell Carcinoma Tumorigenesis by Enhancing c-Myc Stability via YTHDF1-Mediated m6A Modification. METTL3,METTL3,Facilitates Cell Carcinoma Tumorigenesis by,N/A,c Myc Stability
34, METTL3 Facilitates Oral Squamous Cell Carcinoma Tumorigenesis by Enhancing c-Myc Stability via YTHDF1-Mediated m6A Modification. METTL3,METTL3,Facilitates Cell Carcinoma Tumorigenesis by,N/A,Enhancing c Myc Stability
170, RBM15 facilitates laryngeal squamous cell carcinoma progression by regulating TMBIM6 stability through IGF2BP3 dependent. RBM15,RBM15,facilitates cell carcinoma progression through,N/A,IGF2BP3 dependent
170, RBM15 facilitates laryngeal squamous cell carcinoma progression by regulating TMBIM6 stability through IGF2BP3 dependent. RBM15,RBM15,facilitates cell carcinoma progression by,N/A,regulating TMBIM6 stability
170, RBM15 facilitates laryngeal squamous cell carcinoma progression by regulating TMBIM6 stability through IGF2BP3 dependent. RBM15,RBM15,facilitates cell carcinoma progression by,N/A,TMBIM6 stability
404, YTHDF2 facilitates aggresome formation via UPF1 in an m6A-independent manner YTHDF2,YTHDF2,facilitates aggresome formation via,N/A,UPF1
404, YTHDF2 facilitates aggresome formation via UPF1 in an m6A-independent manner YTHDF2,YTHDF2,facilitates aggresome formation in,N/A,m6A independent manner
404, YTHDF2 facilitates aggresome formation via UPF1 in an m6A-independent manner YTHDF2,YTHDF2,facilitates aggresome formation in,N/A,manner
162, YTHDF1 Facilitates the Progression of Hepatocellular Carcinoma by Promoting FZD5 mRNA Translation in an m6A-Dependent Manner. YTHDF1,YTHDF1,Facilitates,STIMULATES,Progression
162, YTHDF1 Facilitates the Progression of Hepatocellular Carcinoma by Promoting FZD5 mRNA Translation in an m6A-Dependent Manner. YTHDF1,YTHDF1,Facilitates,STIMULATES,Progression of Hepatocellular Carcinoma
53, FTO Facilitates Lung Adenocarcinoma Cell Progression by Activating Cell Migration Through mRNA Demethylation. FTO,FTO,Facilitates,STIMULATES,Lung Adenocarcinoma Cell Progression
34, METTL3 Facilitates Oral Squamous Cell Carcinoma Tumorigenesis by Enhancing c-Myc Stability via YTHDF1-Mediated m6A Modification. METTL3,METTL3,Facilitates,STIMULATES,Squamous Cell Carcinoma Tumorigenesis
34, METTL3 Facilitates Oral Squamous Cell Carcinoma Tumorigenesis by Enhancing c-Myc Stability via YTHDF1-Mediated m6A Modification. METTL3,METTL3,Facilitates,STIMULATES,Oral Cell Carcinoma Tumorigenesis
34, METTL3 Facilitates Oral Squamous Cell Carcinoma Tumorigenesis by Enhancing c-Myc Stability via YTHDF1-Mediated m6A Modification. METTL3,METTL3,Facilitates,STIMULATES,Oral Squamous Cell Carcinoma Tumorigenesis
34, METTL3 Facilitates Oral Squamous Cell Carcinoma Tumorigenesis by Enhancing c-Myc Stability via YTHDF1-Mediated m6A Modification. METTL3,METTL3,Facilitates,STIMULATES,Cell Carcinoma Tumorigenesis
82, The m6A Reader YTHDF1 Facilitates the Tumorigenesis and Metastasis of Gastric Cancer via USP14 Translation in an m6A-Dependent Manner. m6A Reader YTHDF1,m6A Reader YTHDF1,Facilitates,STIMULATES,Tumorigenesis
82, The m6A Reader YTHDF1 Facilitates the Tumorigenesis and Metastasis of Gastric Cancer via USP14 Translation in an m6A-Dependent Manner. m6A Reader YTHDF1,m6A Reader YTHDF1,Facilitates,STIMULATES,Tumorigenesis of Cancer
82, The m6A Reader YTHDF1 Facilitates the Tumorigenesis and Metastasis of Gastric Cancer via USP14 Translation in an m6A-Dependent Manner. m6A Reader YTHDF1,m6A Reader YTHDF1,Facilitates,STIMULATES,Tumorigenesis of Gastric Cancer
149, Overexpression of METTL3 attenuates high-glucose induced RPE cell pyroptosis by regulating miR-25-3p/PTEN/Akt signaling cascade through DGCR8. RPE cell pyroptosis,RPE cell pyroptosis,Overexpression of,STIMULATES,METTL3
149, Overexpression of METTL3 attenuates high-glucose induced RPE cell pyroptosis by regulating miR-25-3p/PTEN/Akt signaling cascade through DGCR8. induced RPE cell pyroptosis,induced RPE cell pyroptosis,Overexpression of,STIMULATES,METTL3
352, Activation of the KDM5A/miRNA-495/YTHDF2/m6A-MOB3B axis facilitates prostate cancer progression. prostate cancer progression,prostate cancer progression,Activation of,STIMULATES,YTHDF2 m6A MOB3B axis
241, Progression of Thyroid Carcinoma Is Promoted by the m6A Methyltransferase METTL3 Through Regulating m6A Methylation on TCF1. Progression,Progression,Is Promoted by,STIMULATES,m6A Methyltransferase METTL3
37, ALKBH5 Inhibited Cell Proliferation and Sensitized Bladder Cancer Cells to Cisplatin by m6A-CK2alpha-Mediated Glycolysis. ALKBH5,ALKBH5,Sensitized,SENSITIZES,Bladder Cancer Cells
350, HNRNPA2B1 regulates tamoxifen- and fulvestrant-sensitivity and hallmarks of endocrine resistance in breast cancer cells. HNRNPA2B1,HNRNPA2B1,sensitivity of,SENSITIZES,endocrine resistance
350, HNRNPA2B1 regulates tamoxifen- and fulvestrant-sensitivity and hallmarks of endocrine resistance in breast cancer cells. HNRNPA2B1,HNRNPA2B1,sensitivity of,SENSITIZES,resistance
350, HNRNPA2B1 regulates tamoxifen- and fulvestrant-sensitivity and hallmarks of endocrine resistance in breast cancer cells. HNRNPA2B1,HNRNPA2B1,sensitivity in,SENSITIZES,breast cancer cells
17, Targeting YTHDF1 effectively re-sensitizes cisplatin-resistant colon cancer cells by modulating GLS-mediated glutamine metabolism. Targeting YTHDF1,Targeting YTHDF1,effectively re-sensitizes,SENSITIZES,colon cancer cells
17, Targeting YTHDF1 effectively re-sensitizes cisplatin-resistant colon cancer cells by modulating GLS-mediated glutamine metabolism. YTHDF1,YTHDF1,effectively re-sensitizes,SENSITIZES,colon cancer cells
17, Targeting YTHDF1 effectively re-sensitizes cisplatin-resistant colon cancer cells by modulating GLS-mediated glutamine metabolism. YTHDF1,YTHDF1,effectively re-sensitizes,SENSITIZES,cisplatin resistant colon cancer cells
17, Targeting YTHDF1 effectively re-sensitizes cisplatin-resistant colon cancer cells by modulating GLS-mediated glutamine metabolism. Targeting YTHDF1,Targeting YTHDF1,effectively re-sensitizes,SENSITIZES,cisplatin resistant colon cancer cells
383, Exosomal Delivery of FTO Confers Gefitinib Resistance to Recipient Cells through ABCC10 Regulation in an m6A-dependent Manner. Exosomal Delivery,Exosomal Delivery,Confers,PRODUCES,Gefitinib Resistance
383, Exosomal Delivery of FTO Confers Gefitinib Resistance to Recipient Cells through ABCC10 Regulation in an m6A-dependent Manner. Delivery,Delivery,Confers,PRODUCES,Gefitinib Resistance
361, A defined N6-methyladenosine (m6A) profile conferred by METTL3 regulates muscle stem cell/myoblast state transitions. N6 methyladenosine,N6 methyladenosine,conferred by,PRODUCES,METTL3
175, METTL3-mediated M6A methylation modification is involved in colistin-induced nephrotoxicity through apoptosis mediated by Keap1/Nrf2 signaling pathway. M6A methylation modification,M6A methylation modification,is involved through,PROCESS_OF,apoptosis mediated by Keap1 Nrf2 signaling pathway
175, METTL3-mediated M6A methylation modification is involved in colistin-induced nephrotoxicity through apoptosis mediated by Keap1/Nrf2 signaling pathway. mediated M6A methylation modification,mediated M6A methylation modification,is involved through,PROCESS_OF,apoptosis mediated
175, METTL3-mediated M6A methylation modification is involved in colistin-induced nephrotoxicity through apoptosis mediated by Keap1/Nrf2 signaling pathway. mediated M6A methylation modification,mediated M6A methylation modification,is involved through,PROCESS_OF,apoptosis mediated by Keap1 Nrf2 signaling pathway
175, METTL3-mediated M6A methylation modification is involved in colistin-induced nephrotoxicity through apoptosis mediated by Keap1/Nrf2 signaling pathway. mediated M6A methylation modification,mediated M6A methylation modification,is involved through,PROCESS_OF,apoptosis
175, METTL3-mediated M6A methylation modification is involved in colistin-induced nephrotoxicity through apoptosis mediated by Keap1/Nrf2 signaling pathway. M6A methylation modification,M6A methylation modification,is involved through,PROCESS_OF,apoptosis mediated
175, METTL3-mediated M6A methylation modification is involved in colistin-induced nephrotoxicity through apoptosis mediated by Keap1/Nrf2 signaling pathway. M6A methylation modification,M6A methylation modification,is involved through,PROCESS_OF,apoptosis
389, Stabilization of ERK-Phosphorylated METTL3 by USP5 Increases m6A Methylation. m6A Methylation,m6A Methylation,Stabilization of,MAINTAINS,Phosphorylated METTL3
389, Stabilization of ERK-Phosphorylated METTL3 by USP5 Increases m6A Methylation. m6A Methylation,m6A Methylation,Stabilization of,MAINTAINS,ERK Phosphorylated METTL3
389, Stabilization of ERK-Phosphorylated METTL3 by USP5 Increases m6A Methylation. m6A Methylation,m6A Methylation,Stabilization of,MAINTAINS,METTL3
96, m6A Demethylase ALKBH5 Maintains Tumorigenicity of Glioblastoma Stem-like Cells by Sustaining FOXM1 Expression and Cell Proliferation Program. m6A Demethylase ALKBH5,m6A Demethylase ALKBH5,Maintains,MAINTAINS,Tumorigenicity of Glioblastoma Stem like Cells
96, m6A Demethylase ALKBH5 Maintains Tumorigenicity of Glioblastoma Stem-like Cells by Sustaining FOXM1 Expression and Cell Proliferation Program. m6A Demethylase ALKBH5,m6A Demethylase ALKBH5,Maintains,MAINTAINS,Tumorigenicity
96, m6A Demethylase ALKBH5 Maintains Tumorigenicity of Glioblastoma Stem-like Cells by Sustaining FOXM1 Expression and Cell Proliferation Program. m6A Demethylase ALKBH5,m6A Demethylase ALKBH5,Maintains,MAINTAINS,Tumorigenicity of Glioblastoma Cells
41, METTL3 enhances the stability of MALAT1 with the assistance of HuR via m6A modification and activates NF-kappaB to promote the malignant progression of IDH-wildtype glioma. METTL3,METTL3,enhances stability with,MAINTAINS,assistance
41, METTL3 enhances the stability of MALAT1 with the assistance of HuR via m6A modification and activates NF-kappaB to promote the malignant progression of IDH-wildtype glioma. METTL3,METTL3,enhances stability with,MAINTAINS,assistance via m6A modification
41, METTL3 enhances the stability of MALAT1 with the assistance of HuR via m6A modification and activates NF-kappaB to promote the malignant progression of IDH-wildtype glioma. METTL3,METTL3,enhances stability with,MAINTAINS,assistance of HuR via m6A modification
41, METTL3 enhances the stability of MALAT1 with the assistance of HuR via m6A modification and activates NF-kappaB to promote the malignant progression of IDH-wildtype glioma. METTL3,METTL3,enhances stability with,MAINTAINS,assistance of HuR
375, The human 18S rRNA m6A methyltransferase METTL5 is stabilized by TRMT112. 18S rRNA m6A methyltransferase METTL5,18S rRNA m6A methyltransferase METTL5,is stabilized by,MAINTAINS,TRMT112
375, The human 18S rRNA m6A methyltransferase METTL5 is stabilized by TRMT112. human 18S rRNA m6A methyltransferase METTL5,human 18S rRNA m6A methyltransferase METTL5,is stabilized by,MAINTAINS,TRMT112
103, METTL3 Promotes the Progression of Gastric Cancer via Targeting the MYC Pathway. METTL3,METTL3,Targeting,INTERACTS_WITH,MYC Pathway
353, Targeting the RNA m6A Reader YTHDF2 Selectively Compromises Cancer Stem Cells in Acute Myeloid Leukemia. Cancer Stem Cells,Cancer Stem Cells,Targeting,INTERACTS_WITH,RNA m6A Reader YTHDF2
353, Targeting the RNA m6A Reader YTHDF2 Selectively Compromises Cancer Stem Cells in Acute Myeloid Leukemia. Compromises Cancer Stem Cells,Compromises Cancer Stem Cells,Targeting,INTERACTS_WITH,RNA m6A Reader YTHDF2
134, Binding to m6A RNA promotes YTHDF2-mediated phase separation. phase separation,phase separation,Binding to,INTERACTS_WITH,m6A RNA
134, Binding to m6A RNA promotes YTHDF2-mediated phase separation. mediated phase separation,mediated phase separation,Binding to,INTERACTS_WITH,m6A RNA
346, PBRM1 Cooperates with YTHDF2 to Control HIF-1alpha Protein Translation. PBRM1,PBRM1,Cooperates with,INTERACTS_WITH,YTHDF2
346, PBRM1 Cooperates with YTHDF2 to Control HIF-1alpha Protein Translation. PBRM1,PBRM1,Cooperates with,INTERACTS_WITH,YTHDF2 to Control HIF 1alpha Protein Translation
115, Long noncoding RNA GAS5 inhibits progression of colorectal cancer by interacting with and triggering YAP phosphorylation and degradation and is negatively regulated by the m6A reader YTHDF3. Long noncoding RNA GAS5,Long noncoding RNA GAS5,is negatively regulated by,INHIBITS,m6A reader YTHDF3
419, Gemcitabine Inhibits the Progression of Pancreatic Cancer by Restraining the WTAP/MYC Chain in an m6A-dependent Manner. Gemcitabine,Gemcitabine,Inhibits by,INHIBITS,Progression of Cancer
419, Gemcitabine Inhibits the Progression of Pancreatic Cancer by Restraining the WTAP/MYC Chain in an m6A-dependent Manner. Gemcitabine,Gemcitabine,Inhibits by,INHIBITS,Progression
419, Gemcitabine Inhibits the Progression of Pancreatic Cancer by Restraining the WTAP/MYC Chain in an m6A-dependent Manner. Gemcitabine,Gemcitabine,Inhibits by,INHIBITS,Progression of Pancreatic Cancer
2, METTL14 Overexpression Promotes Osteosarcoma Cell Apoptosis and Slows Tumor Progression via Caspase 3 Activation. METTL14 Overexpression,METTL14 Overexpression,Slows,INHIBITS,Tumor Progression
303, Silencing of METTL3 effectively hinders invasion and metastasis of prostate cancer cells. invasion,invasion,Silencing of,INHIBITS,METTL3
303, Silencing of METTL3 effectively hinders invasion and metastasis of prostate cancer cells. invasion,invasion,Silencing,INHIBITS,metastasis
129, Meclofenamic acid selectively inhibits FTO demethylation of m6A over ALKBH5. acid,acid,selectively inhibits,INHIBITS,FTO demethylation
129, Meclofenamic acid selectively inhibits FTO demethylation of m6A over ALKBH5. Meclofenamic acid,Meclofenamic acid,selectively inhibits,INHIBITS,FTO demethylation of m6A
129, Meclofenamic acid selectively inhibits FTO demethylation of m6A over ALKBH5. Meclofenamic acid,Meclofenamic acid,selectively inhibits,INHIBITS,FTO demethylation
129, Meclofenamic acid selectively inhibits FTO demethylation of m6A over ALKBH5. acid,acid,selectively inhibits,INHIBITS,FTO demethylation of m6A
145, Knockdown of METTL3 inhibits enterovirus 71 induced apoptosis of mouse Schwann cell through regulation of autophagy. enterovirus 71 induced apoptosis,enterovirus 71 induced apoptosis,Knockdown of,INHIBITS,METTL3
145, Knockdown of METTL3 inhibits enterovirus 71 induced apoptosis of mouse Schwann cell through regulation of autophagy. enterovirus 71 apoptosis,enterovirus 71 apoptosis,Knockdown of,INHIBITS,METTL3
72, METTL14 Suppresses CRC Progression via Regulating N6-Methyladenosine-Dependent Primary miR-375 Processing. METTL14,METTL14,Suppresses,INHIBITS,CRC Progression
419, Gemcitabine Inhibits the Progression of Pancreatic Cancer by Restraining the WTAP/MYC Chain in an m6A-dependent Manner. Gemcitabine,Gemcitabine,Inhibits,INHIBITS,Progression of Pancreatic Cancer
419, Gemcitabine Inhibits the Progression of Pancreatic Cancer by Restraining the WTAP/MYC Chain in an m6A-dependent Manner. Gemcitabine,Gemcitabine,Inhibits,INHIBITS,Progression
419, Gemcitabine Inhibits the Progression of Pancreatic Cancer by Restraining the WTAP/MYC Chain in an m6A-dependent Manner. Gemcitabine,Gemcitabine,Inhibits,INHIBITS,Progression of Cancer
261, YTHDF2 Inhibits Gastric Cancer Cell Growth by Regulating FOXC2 Signaling Pathway. YTHDF2,YTHDF2,Inhibits,INHIBITS,Gastric Cancer Cell Growth
261, YTHDF2 Inhibits Gastric Cancer Cell Growth by Regulating FOXC2 Signaling Pathway. YTHDF2,YTHDF2,Inhibits,INHIBITS,Cancer Cell Growth
16, Hsa-let-7b-5p Inhibits Proliferation of Human Leukemia THP-1 Cells via FTO/m6A/MYC Signaling Pathway. 7b 5p,7b 5p,Inhibits,INHIBITS,Proliferation of Human Leukemia THP 1 Cells
16, Hsa-let-7b-5p Inhibits Proliferation of Human Leukemia THP-1 Cells via FTO/m6A/MYC Signaling Pathway. 7b 5p,7b 5p,Inhibits,INHIBITS,Proliferation
16, Hsa-let-7b-5p Inhibits Proliferation of Human Leukemia THP-1 Cells via FTO/m6A/MYC Signaling Pathway. 7b 5p,7b 5p,Inhibits,INHIBITS,Proliferation of Leukemia THP 1 Cells
28, ALKBH5 Inhibits Pancreatic Cancer Motility by Decreasing Long Non-Coding RNA KCNK15-AS1 Methylation. ALKBH5,ALKBH5,Inhibits,INHIBITS,Pancreatic Cancer Motility
28, ALKBH5 Inhibits Pancreatic Cancer Motility by Decreasing Long Non-Coding RNA KCNK15-AS1 Methylation. ALKBH5,ALKBH5,Inhibits,INHIBITS,Cancer Motility
31, METTL14 Inhibits Hepatocellular Carcinoma Metastasis Through Regulating EGFR/PI3K/AKT Signaling Pathway in an m6A-Dependent Manner. METTL14,METTL14,Inhibits,INHIBITS,Hepatocellular Carcinoma Metastasis
73, The m6A Methyltransferase METTL14-Mediated N6-Methyladenosine Modification of PTEN mRNA Inhibits Tumor Growth and Metastasis in Stomach Adenocarcinoma. m6A Methyltransferase Mediated N6 Methyladenosine Modification,m6A Methyltransferase Mediated N6 Methyladenosine Modification,Inhibits,INHIBITS,Tumor Growth
73, The m6A Methyltransferase METTL14-Mediated N6-Methyladenosine Modification of PTEN mRNA Inhibits Tumor Growth and Metastasis in Stomach Adenocarcinoma. m6A Methyltransferase N6 Methyladenosine Modification,m6A Methyltransferase N6 Methyladenosine Modification,Inhibits,INHIBITS,Tumor Growth
118, Loading MicroRNA-376c in Extracellular Vesicles Inhibits Properties of Non-Small Cell Lung Cancer Cells by Targeting YTHDF1. Loading MicroRNA 376c,Loading MicroRNA 376c,Inhibits,INHIBITS,Properties of Non-Small Cell Lung Cancer Cells
118, Loading MicroRNA-376c in Extracellular Vesicles Inhibits Properties of Non-Small Cell Lung Cancer Cells by Targeting YTHDF1. MicroRNA 376c,MicroRNA 376c,Inhibits,INHIBITS,Properties
118, Loading MicroRNA-376c in Extracellular Vesicles Inhibits Properties of Non-Small Cell Lung Cancer Cells by Targeting YTHDF1. Loading MicroRNA 376c,Loading MicroRNA 376c,Inhibits,INHIBITS,Properties
118, Loading MicroRNA-376c in Extracellular Vesicles Inhibits Properties of Non-Small Cell Lung Cancer Cells by Targeting YTHDF1. MicroRNA 376c,MicroRNA 376c,Inhibits,INHIBITS,Properties of Non-Small Cell Lung Cancer Cells
362, Deficiency of Mettl3 in Bladder Cancer Stem Cells Inhibits Bladder Cancer Progression and Angiogenesis. Deficiency,Deficiency,Inhibits,INHIBITS,Bladder Cancer Progression
363, Corrigendum: Deficiency of Mettl3 in Bladder Cancer Stem Cells Inhibits Bladder Cancer Progression and Angiogenesis. Deficiency,Deficiency,Inhibits,INHIBITS,Bladder Cancer Progression
275, METTL14 Inhibits Hematopoietic Stem/Progenitor Differentiation and Promotes Leukemogenesis via mRNA m6A Modification. METTL14,METTL14,Inhibits,INHIBITS,Hematopoietic Stem Progenitor Differentiation
275, METTL14 Inhibits Hematopoietic Stem/Progenitor Differentiation and Promotes Leukemogenesis via mRNA m6A Modification. METTL14,METTL14,Inhibits,INHIBITS,Stem Progenitor Differentiation
124, Inhibition of METTL3/m6A/miR126 promotes the migration and invasion of endometrial stromal cells in endometriosis. migration,migration,Inhibition of,INHIBITS,METTL3 m6A miR126
124, Inhibition of METTL3/m6A/miR126 promotes the migration and invasion of endometrial stromal cells in endometriosis. migration,migration,Inhibition,INHIBITS,invasion
37, ALKBH5 Inhibited Cell Proliferation and Sensitized Bladder Cancer Cells to Cisplatin by m6A-CK2alpha-Mediated Glycolysis. ALKBH5,ALKBH5,Inhibited,INHIBITS,Cell Proliferation
421, Xanthine derivatives inhibit FTO in an L-ascorbic acid-dependent manner. Xanthine derivatives,Xanthine derivatives,inhibit FTO in,INHIBITS,manner
421, Xanthine derivatives inhibit FTO in an L-ascorbic acid-dependent manner. Xanthine derivatives,Xanthine derivatives,inhibit FTO in,INHIBITS,acid dependent manner
421, Xanthine derivatives inhibit FTO in an L-ascorbic acid-dependent manner. derivatives,derivatives,inhibit FTO in,INHIBITS,L ascorbic manner
421, Xanthine derivatives inhibit FTO in an L-ascorbic acid-dependent manner. Xanthine derivatives,Xanthine derivatives,inhibit FTO in,INHIBITS,L ascorbic acid dependent manner
421, Xanthine derivatives inhibit FTO in an L-ascorbic acid-dependent manner. derivatives,derivatives,inhibit FTO in,INHIBITS,manner
421, Xanthine derivatives inhibit FTO in an L-ascorbic acid-dependent manner. derivatives,derivatives,inhibit FTO in,INHIBITS,acid dependent manner
421, Xanthine derivatives inhibit FTO in an L-ascorbic acid-dependent manner. Xanthine derivatives,Xanthine derivatives,inhibit FTO in,INHIBITS,L ascorbic manner
421, Xanthine derivatives inhibit FTO in an L-ascorbic acid-dependent manner. derivatives,derivatives,inhibit FTO in,INHIBITS,L ascorbic acid dependent manner
13, Triclosan-induced abnormal expression of miR-30b regulates fto-mediated m6A methylation level to cause lipid metabolism disorder in zebrafish. mediated m6A methylation level,mediated m6A methylation level,induced abnormal expression of,INHIBITS,miR 30b
13, Triclosan-induced abnormal expression of miR-30b regulates fto-mediated m6A methylation level to cause lipid metabolism disorder in zebrafish. m6A methylation level,m6A methylation level,induced abnormal expression of,INHIBITS,miR 30b
379, Loss of WTAP Impairs Early Parthenogenetic Embryo Development. Loss,Loss,Impairs,INHIBITS,Embryo Development
379, Loss of WTAP Impairs Early Parthenogenetic Embryo Development. Loss,Loss,Impairs,INHIBITS,Early Embryo Development
379, Loss of WTAP Impairs Early Parthenogenetic Embryo Development. Loss,Loss,Impairs,INHIBITS,Parthenogenetic Embryo Development
379, Loss of WTAP Impairs Early Parthenogenetic Embryo Development. Loss,Loss,Impairs,INHIBITS,Early Parthenogenetic Embryo Development
323, m6A-RNA Demethylase FTO Inhibitors Impair Self-Renewal in Glioblastoma Stem Cells. m6A RNA Demethylase FTO Inhibitors,m6A RNA Demethylase FTO Inhibitors,Impair,INHIBITS,Self Renewal
268, METTL3/m6A/miRNA-873-5p Attenuated Oxidative Stress and Apoptosis in Colistin-Induced Kidney Injury by Modulating Keap1/Nrf2 Pathway. METTL3 m6A miRNA -873-5p,METTL3 m6A miRNA -873-5p,Attenuated,INHIBITS,Oxidative Stress
268, METTL3/m6A/miRNA-873-5p Attenuated Oxidative Stress and Apoptosis in Colistin-Induced Kidney Injury by Modulating Keap1/Nrf2 Pathway. METTL3 m6A miRNA -873-5p,METTL3 m6A miRNA -873-5p,Attenuated,INHIBITS,Stress
303, Silencing of METTL3 effectively hinders invasion and metastasis of prostate cancer cells. Silencing,Silencing,effectively hinders,INHIBITS,invasion of prostate cancer cells
303, Silencing of METTL3 effectively hinders invasion and metastasis of prostate cancer cells. Silencing,Silencing,effectively hinders,INHIBITS,invasion
3, Downregulation of m6A Reader YTHDC2 Promotes the Proliferation and Migration of Malignant Lung Cells via CYLD/NF-kappaB Pathway. Proliferation,Proliferation,Downregulation of,INHIBITS,m6A Reader YTHDC2
3, Downregulation of m6A Reader YTHDC2 Promotes the Proliferation and Migration of Malignant Lung Cells via CYLD/NF-kappaB Pathway. Proliferation,Proliferation,Downregulation,INHIBITS,Migration
362, Deficiency of Mettl3 in Bladder Cancer Stem Cells Inhibits Bladder Cancer Progression and Angiogenesis. Bladder Cancer Progression,Bladder Cancer Progression,Deficiency of,INHIBITS,Mettl3
363, Corrigendum: Deficiency of Mettl3 in Bladder Cancer Stem Cells Inhibits Bladder Cancer Progression and Angiogenesis. Bladder Cancer Progression,Bladder Cancer Progression,Deficiency of,INHIBITS,Mettl3
368, Conditional deficiency of m6A methyltransferase Mettl14 in substantia nigra alters dopaminergic neuron function. dopaminergic neuron function,dopaminergic neuron function,deficiency of,INHIBITS,m6A methyltransferase Mettl14
368, Conditional deficiency of m6A methyltransferase Mettl14 in substantia nigra alters dopaminergic neuron function. neuron function,neuron function,deficiency of,INHIBITS,m6A methyltransferase Mettl14
362, Deficiency of Mettl3 in Bladder Cancer Stem Cells Inhibits Bladder Cancer Progression and Angiogenesis. Bladder Cancer Progression,Bladder Cancer Progression,Deficiency in,INHIBITS,Bladder Cancer Stem Cells
363, Corrigendum: Deficiency of Mettl3 in Bladder Cancer Stem Cells Inhibits Bladder Cancer Progression and Angiogenesis. Bladder Cancer Progression,Bladder Cancer Progression,Deficiency in,INHIBITS,Bladder Cancer Stem Cells
368, Conditional deficiency of m6A methyltransferase Mettl14 in substantia nigra alters dopaminergic neuron function. dopaminergic neuron function,dopaminergic neuron function,deficiency in,INHIBITS,substantia nigra
368, Conditional deficiency of m6A methyltransferase Mettl14 in substantia nigra alters dopaminergic neuron function. neuron function,neuron function,deficiency in,INHIBITS,substantia nigra
362, Deficiency of Mettl3 in Bladder Cancer Stem Cells Inhibits Bladder Cancer Progression and Angiogenesis. Bladder Cancer Progression,Bladder Cancer Progression,Deficiency,INHIBITS,Angiogenesis
363, Corrigendum: Deficiency of Mettl3 in Bladder Cancer Stem Cells Inhibits Bladder Cancer Progression and Angiogenesis. Bladder Cancer Progression,Bladder Cancer Progression,Deficiency,INHIBITS,Angiogenesis
315, Loss of the RNA-binding protein Rbm15 disrupts liver maturation in zebrafish. Loss Rbm15,Loss Rbm15,disrupts liver maturation in,DISRUPTS,zebrafish
227, YTHDF1 Aggravates the Progression of Cervical Cancer Through m6A-Mediated Up-Regulation of RANBP2. YTHDF1,YTHDF1,Aggravates,COMPLICATES,Progression of Cervical Cancer
227, YTHDF1 Aggravates the Progression of Cervical Cancer Through m6A-Mediated Up-Regulation of RANBP2. YTHDF1,YTHDF1,Aggravates,COMPLICATES,Progression
199, m6A mRNA methylation initiated by METTL3 directly promotes YAP translation and increases YAP activity by regulating the MALAT1-miR-1914-3p-YAP axis to induce NSCLC drug resistance and metastasis. m6A mRNA methylation,m6A mRNA methylation,initiated directly by,CAUSES,METTL3
199, m6A mRNA methylation initiated by METTL3 directly promotes YAP translation and increases YAP activity by regulating the MALAT1-miR-1914-3p-YAP axis to induce NSCLC drug resistance and metastasis. m6A mRNA methylation,m6A mRNA methylation,initiated by,CAUSES,METTL3
5, VIRMA contributes to non-small cell lung cancer progression via N6-methyladenosine-dependent DAPK3 post-transcriptional modification. VIRMA,VIRMA,contributes via,CAUSES,DAPK3 modification
5, VIRMA contributes to non-small cell lung cancer progression via N6-methyladenosine-dependent DAPK3 post-transcriptional modification. VIRMA,VIRMA,contributes via,CAUSES,N6 methyladenosine dependent DAPK3 post-transcriptional modification
5, VIRMA contributes to non-small cell lung cancer progression via N6-methyladenosine-dependent DAPK3 post-transcriptional modification. VIRMA,VIRMA,contributes via,CAUSES,N6 methyladenosine dependent DAPK3 modification
5, VIRMA contributes to non-small cell lung cancer progression via N6-methyladenosine-dependent DAPK3 post-transcriptional modification. VIRMA,VIRMA,contributes via,CAUSES,DAPK3 post-transcriptional modification
174, The m6A methyltransferase METTL3 contributes to Transforming Growth Factor-beta-induced epithelial-mesenchymal transition of lung cancer cells through the regulation of JUNB. m6A methyltransferase METTL3,m6A methyltransferase METTL3,contributes through,CAUSES,regulation
174, The m6A methyltransferase METTL3 contributes to Transforming Growth Factor-beta-induced epithelial-mesenchymal transition of lung cancer cells through the regulation of JUNB. m6A methyltransferase METTL3,m6A methyltransferase METTL3,contributes through,CAUSES,regulation of JUNB
309, SEDT2/METTL14-mediated m6A methylation awakening contributes to hypoxia-induced pulmonary arterial hypertension in mice. mediated m6A methylation awakening,mediated m6A methylation awakening,contributes in,CAUSES,mice
309, SEDT2/METTL14-mediated m6A methylation awakening contributes to hypoxia-induced pulmonary arterial hypertension in mice. m6A methylation awakening,m6A methylation awakening,contributes in,CAUSES,mice
8, METTL3 contributes to renal ischemia-reperfusion injury by regulating Foxd1 methylation. METTL3,METTL3,contributes by,CAUSES,regulating Foxd1 methylation
8, METTL3 contributes to renal ischemia-reperfusion injury by regulating Foxd1 methylation. METTL3,METTL3,contributes by,CAUSES,Foxd1 methylation
164, N6-Methyladenosine Demethylase FTO Contributes to Neuropathic Pain by Stabilizing G9a Expression in Primary Sensory Neurons. N6 Methyladenosine Demethylase FTO,N6 Methyladenosine Demethylase FTO,Contributes by,CAUSES,Stabilizing G9a Expression in Primary Neurons
164, N6-Methyladenosine Demethylase FTO Contributes to Neuropathic Pain by Stabilizing G9a Expression in Primary Sensory Neurons. N6 Methyladenosine Demethylase FTO,N6 Methyladenosine Demethylase FTO,Contributes by,CAUSES,Stabilizing G9a Expression in Primary Sensory Neurons
164, N6-Methyladenosine Demethylase FTO Contributes to Neuropathic Pain by Stabilizing G9a Expression in Primary Sensory Neurons. N6 Methyladenosine Demethylase FTO,N6 Methyladenosine Demethylase FTO,Contributes by,CAUSES,G9a Expression in Neurons
164, N6-Methyladenosine Demethylase FTO Contributes to Neuropathic Pain by Stabilizing G9a Expression in Primary Sensory Neurons. N6 Methyladenosine Demethylase FTO,N6 Methyladenosine Demethylase FTO,Contributes by,CAUSES,G9a Expression in Sensory Neurons
164, N6-Methyladenosine Demethylase FTO Contributes to Neuropathic Pain by Stabilizing G9a Expression in Primary Sensory Neurons. N6 Methyladenosine Demethylase FTO,N6 Methyladenosine Demethylase FTO,Contributes by,CAUSES,G9a Expression in Primary Neurons
164, N6-Methyladenosine Demethylase FTO Contributes to Neuropathic Pain by Stabilizing G9a Expression in Primary Sensory Neurons. N6 Methyladenosine Demethylase FTO,N6 Methyladenosine Demethylase FTO,Contributes by,CAUSES,Stabilizing G9a Expression
164, N6-Methyladenosine Demethylase FTO Contributes to Neuropathic Pain by Stabilizing G9a Expression in Primary Sensory Neurons. N6 Methyladenosine Demethylase FTO,N6 Methyladenosine Demethylase FTO,Contributes by,CAUSES,Stabilizing G9a Expression in Neurons
164, N6-Methyladenosine Demethylase FTO Contributes to Neuropathic Pain by Stabilizing G9a Expression in Primary Sensory Neurons. N6 Methyladenosine Demethylase FTO,N6 Methyladenosine Demethylase FTO,Contributes by,CAUSES,Stabilizing G9a Expression in Sensory Neurons
164, N6-Methyladenosine Demethylase FTO Contributes to Neuropathic Pain by Stabilizing G9a Expression in Primary Sensory Neurons. N6 Methyladenosine Demethylase FTO,N6 Methyladenosine Demethylase FTO,Contributes by,CAUSES,G9a Expression in Primary Sensory Neurons
164, N6-Methyladenosine Demethylase FTO Contributes to Neuropathic Pain by Stabilizing G9a Expression in Primary Sensory Neurons. N6 Methyladenosine Demethylase FTO,N6 Methyladenosine Demethylase FTO,Contributes by,CAUSES,G9a Expression
79, Methylation of Structured RNA by the m6A Writer METTL16 Is Essential for Mouse Embryonic Development. Methylation,Methylation,Is Essential for,CAUSES,Mouse Embryonic Development
189, Regulation of m6A Transcripts by the 3' 5' RNA Helicase YTHDC2 Is Essential for a Successful Meiotic Program in the Mammalian Germline. Regulation,Regulation,Is Essential for,CAUSES,Successful Program in Germline
189, Regulation of m6A Transcripts by the 3' 5' RNA Helicase YTHDC2 Is Essential for a Successful Meiotic Program in the Mammalian Germline. Regulation,Regulation,Is Essential for,CAUSES,Program
189, Regulation of m6A Transcripts by the 3' 5' RNA Helicase YTHDC2 Is Essential for a Successful Meiotic Program in the Mammalian Germline. Regulation,Regulation,Is Essential for,CAUSES,Successful Program in Mammalian Germline
189, Regulation of m6A Transcripts by the 3' 5' RNA Helicase YTHDC2 Is Essential for a Successful Meiotic Program in the Mammalian Germline. Regulation,Regulation,Is Essential for,CAUSES,Program in Mammalian Germline
189, Regulation of m6A Transcripts by the 3' 5' RNA Helicase YTHDC2 Is Essential for a Successful Meiotic Program in the Mammalian Germline. Regulation,Regulation,Is Essential for,CAUSES,Program in Germline
189, Regulation of m6A Transcripts by the 3' 5' RNA Helicase YTHDC2 Is Essential for a Successful Meiotic Program in the Mammalian Germline. Regulation,Regulation,Is Essential for,CAUSES,Successful Meiotic Program in Germline
189, Regulation of m6A Transcripts by the 3' 5' RNA Helicase YTHDC2 Is Essential for a Successful Meiotic Program in the Mammalian Germline. Regulation,Regulation,Is Essential for,CAUSES,Successful Meiotic Program in Mammalian Germline
189, Regulation of m6A Transcripts by the 3' 5' RNA Helicase YTHDC2 Is Essential for a Successful Meiotic Program in the Mammalian Germline. Regulation,Regulation,Is Essential for,CAUSES,Successful Program
189, Regulation of m6A Transcripts by the 3' 5' RNA Helicase YTHDC2 Is Essential for a Successful Meiotic Program in the Mammalian Germline. Regulation,Regulation,Is Essential for,CAUSES,Meiotic Program in Mammalian Germline
189, Regulation of m6A Transcripts by the 3' 5' RNA Helicase YTHDC2 Is Essential for a Successful Meiotic Program in the Mammalian Germline. Regulation,Regulation,Is Essential for,CAUSES,Successful Meiotic Program
189, Regulation of m6A Transcripts by the 3' 5' RNA Helicase YTHDC2 Is Essential for a Successful Meiotic Program in the Mammalian Germline. Regulation,Regulation,Is Essential for,CAUSES,Meiotic Program in Germline
189, Regulation of m6A Transcripts by the 3' 5' RNA Helicase YTHDC2 Is Essential for a Successful Meiotic Program in the Mammalian Germline. Regulation,Regulation,Is Essential for,CAUSES,Meiotic Program
337, The RNA m6A Reader YTHDF2 Is Essential for the Post-transcriptional Regulation of the Maternal Transcriptome and Oocyte Competence. RNA m6A Reader YTHDF2,RNA m6A Reader YTHDF2,Is Essential for,CAUSES,Post-transcriptional Regulation
337, The RNA m6A Reader YTHDF2 Is Essential for the Post-transcriptional Regulation of the Maternal Transcriptome and Oocyte Competence. RNA m6A Reader YTHDF2,RNA m6A Reader YTHDF2,Is Essential for,CAUSES,Regulation of Transcriptome
337, The RNA m6A Reader YTHDF2 Is Essential for the Post-transcriptional Regulation of the Maternal Transcriptome and Oocyte Competence. RNA m6A Reader YTHDF2,RNA m6A Reader YTHDF2,Is Essential for,CAUSES,Post-transcriptional Regulation of Transcriptome
337, The RNA m6A Reader YTHDF2 Is Essential for the Post-transcriptional Regulation of the Maternal Transcriptome and Oocyte Competence. RNA m6A Reader YTHDF2,RNA m6A Reader YTHDF2,Is Essential for,CAUSES,Regulation of Maternal Transcriptome
337, The RNA m6A Reader YTHDF2 Is Essential for the Post-transcriptional Regulation of the Maternal Transcriptome and Oocyte Competence. RNA m6A Reader YTHDF2,RNA m6A Reader YTHDF2,Is Essential for,CAUSES,Post-transcriptional Regulation of Maternal Transcriptome
337, The RNA m6A Reader YTHDF2 Is Essential for the Post-transcriptional Regulation of the Maternal Transcriptome and Oocyte Competence. RNA m6A Reader YTHDF2,RNA m6A Reader YTHDF2,Is Essential for,CAUSES,Regulation
354, N6-Methyladenosine Landscape of Glioma Stem-Like Cells: METTL3 Is Essential for the Expression of Actively Transcribed Genes and Sustenance of the Oncogenic Signaling. METTL3,METTL3,Is Essential for,CAUSES,Expression of Actively Transcribed Genes of Oncogenic Signaling
354, N6-Methyladenosine Landscape of Glioma Stem-Like Cells: METTL3 Is Essential for the Expression of Actively Transcribed Genes and Sustenance of the Oncogenic Signaling. METTL3,METTL3,Is Essential for,CAUSES,Expression of Genes
354, N6-Methyladenosine Landscape of Glioma Stem-Like Cells: METTL3 Is Essential for the Expression of Actively Transcribed Genes and Sustenance of the Oncogenic Signaling. METTL3,METTL3,Is Essential for,CAUSES,Expression of Actively Transcribed Genes
354, N6-Methyladenosine Landscape of Glioma Stem-Like Cells: METTL3 Is Essential for the Expression of Actively Transcribed Genes and Sustenance of the Oncogenic Signaling. METTL3,METTL3,Is Essential for,CAUSES,Expression of Transcribed Genes
354, N6-Methyladenosine Landscape of Glioma Stem-Like Cells: METTL3 Is Essential for the Expression of Actively Transcribed Genes and Sustenance of the Oncogenic Signaling. METTL3,METTL3,Is Essential for,CAUSES,Expression of Genes of Oncogenic Signaling
354, N6-Methyladenosine Landscape of Glioma Stem-Like Cells: METTL3 Is Essential for the Expression of Actively Transcribed Genes and Sustenance of the Oncogenic Signaling. METTL3,METTL3,Is Essential for,CAUSES,Expression
354, N6-Methyladenosine Landscape of Glioma Stem-Like Cells: METTL3 Is Essential for the Expression of Actively Transcribed Genes and Sustenance of the Oncogenic Signaling. METTL3,METTL3,Is Essential for,CAUSES,Expression of Transcribed Genes of Oncogenic Signaling
123, Targeting SLC3A2 subunit of system XC- is essential for m6A reader YTHDC2 to be an endogenous ferroptosis inducer in lung adenocarcinoma. Targeting SLC3A2 subunit,Targeting SLC3A2 subunit,is essential,CAUSES,for ferroptosis inducer in lung adenocarcinoma
123, Targeting SLC3A2 subunit of system XC- is essential for m6A reader YTHDC2 to be an endogenous ferroptosis inducer in lung adenocarcinoma. Targeting SLC3A2 subunit,Targeting SLC3A2 subunit,is essential,CAUSES,ferroptosis inducer in lung adenocarcinoma
123, Targeting SLC3A2 subunit of system XC- is essential for m6A reader YTHDC2 to be an endogenous ferroptosis inducer in lung adenocarcinoma. Targeting SLC3A2 subunit,Targeting SLC3A2 subunit,is essential,CAUSES,ferroptosis inducer
123, Targeting SLC3A2 subunit of system XC- is essential for m6A reader YTHDC2 to be an endogenous ferroptosis inducer in lung adenocarcinoma. Targeting SLC3A2 subunit,Targeting SLC3A2 subunit,is essential,CAUSES,to endogenous ferroptosis inducer
123, Targeting SLC3A2 subunit of system XC- is essential for m6A reader YTHDC2 to be an endogenous ferroptosis inducer in lung adenocarcinoma. SLC3A2 subunit,SLC3A2 subunit,is essential,CAUSES,for endogenous ferroptosis inducer
123, Targeting SLC3A2 subunit of system XC- is essential for m6A reader YTHDC2 to be an endogenous ferroptosis inducer in lung adenocarcinoma. SLC3A2 subunit,SLC3A2 subunit,is essential,CAUSES,endogenous ferroptosis inducer in lung adenocarcinoma
123, Targeting SLC3A2 subunit of system XC- is essential for m6A reader YTHDC2 to be an endogenous ferroptosis inducer in lung adenocarcinoma. SLC3A2 subunit,SLC3A2 subunit,is essential,CAUSES,for ferroptosis inducer in lung adenocarcinoma
123, Targeting SLC3A2 subunit of system XC- is essential for m6A reader YTHDC2 to be an endogenous ferroptosis inducer in lung adenocarcinoma. SLC3A2 subunit,SLC3A2 subunit,is essential,CAUSES,for to endogenous ferroptosis inducer in lung adenocarcinoma
123, Targeting SLC3A2 subunit of system XC- is essential for m6A reader YTHDC2 to be an endogenous ferroptosis inducer in lung adenocarcinoma. Targeting SLC3A2 subunit,Targeting SLC3A2 subunit,is essential,CAUSES,for ferroptosis inducer
123, Targeting SLC3A2 subunit of system XC- is essential for m6A reader YTHDC2 to be an endogenous ferroptosis inducer in lung adenocarcinoma. SLC3A2 subunit,SLC3A2 subunit,is essential,CAUSES,endogenous ferroptosis inducer
123, Targeting SLC3A2 subunit of system XC- is essential for m6A reader YTHDC2 to be an endogenous ferroptosis inducer in lung adenocarcinoma. SLC3A2 subunit,SLC3A2 subunit,is essential,CAUSES,for to endogenous ferroptosis inducer
123, Targeting SLC3A2 subunit of system XC- is essential for m6A reader YTHDC2 to be an endogenous ferroptosis inducer in lung adenocarcinoma. SLC3A2 subunit,SLC3A2 subunit,is essential,CAUSES,to endogenous ferroptosis inducer in lung adenocarcinoma
123, Targeting SLC3A2 subunit of system XC- is essential for m6A reader YTHDC2 to be an endogenous ferroptosis inducer in lung adenocarcinoma. SLC3A2 subunit,SLC3A2 subunit,is essential,CAUSES,ferroptosis inducer in lung adenocarcinoma
123, Targeting SLC3A2 subunit of system XC- is essential for m6A reader YTHDC2 to be an endogenous ferroptosis inducer in lung adenocarcinoma. SLC3A2 subunit,SLC3A2 subunit,is essential,CAUSES,for ferroptosis inducer
123, Targeting SLC3A2 subunit of system XC- is essential for m6A reader YTHDC2 to be an endogenous ferroptosis inducer in lung adenocarcinoma. SLC3A2 subunit,SLC3A2 subunit,is essential,CAUSES,ferroptosis inducer
123, Targeting SLC3A2 subunit of system XC- is essential for m6A reader YTHDC2 to be an endogenous ferroptosis inducer in lung adenocarcinoma. Targeting SLC3A2 subunit,Targeting SLC3A2 subunit,is essential,CAUSES,endogenous ferroptosis inducer in lung adenocarcinoma
123, Targeting SLC3A2 subunit of system XC- is essential for m6A reader YTHDC2 to be an endogenous ferroptosis inducer in lung adenocarcinoma. Targeting SLC3A2 subunit,Targeting SLC3A2 subunit,is essential,CAUSES,for to ferroptosis inducer in lung adenocarcinoma
123, Targeting SLC3A2 subunit of system XC- is essential for m6A reader YTHDC2 to be an endogenous ferroptosis inducer in lung adenocarcinoma. Targeting SLC3A2 subunit,Targeting SLC3A2 subunit,is essential,CAUSES,to ferroptosis inducer
123, Targeting SLC3A2 subunit of system XC- is essential for m6A reader YTHDC2 to be an endogenous ferroptosis inducer in lung adenocarcinoma. Targeting SLC3A2 subunit,Targeting SLC3A2 subunit,is essential,CAUSES,to endogenous ferroptosis inducer in lung adenocarcinoma
123, Targeting SLC3A2 subunit of system XC- is essential for m6A reader YTHDC2 to be an endogenous ferroptosis inducer in lung adenocarcinoma. Targeting SLC3A2 subunit,Targeting SLC3A2 subunit,is essential,CAUSES,endogenous ferroptosis inducer
123, Targeting SLC3A2 subunit of system XC- is essential for m6A reader YTHDC2 to be an endogenous ferroptosis inducer in lung adenocarcinoma. Targeting SLC3A2 subunit,Targeting SLC3A2 subunit,is essential,CAUSES,for to endogenous ferroptosis inducer in lung adenocarcinoma
123, Targeting SLC3A2 subunit of system XC- is essential for m6A reader YTHDC2 to be an endogenous ferroptosis inducer in lung adenocarcinoma. SLC3A2 subunit,SLC3A2 subunit,is essential,CAUSES,for to ferroptosis inducer
123, Targeting SLC3A2 subunit of system XC- is essential for m6A reader YTHDC2 to be an endogenous ferroptosis inducer in lung adenocarcinoma. Targeting SLC3A2 subunit,Targeting SLC3A2 subunit,is essential,CAUSES,for endogenous ferroptosis inducer in lung adenocarcinoma
123, Targeting SLC3A2 subunit of system XC- is essential for m6A reader YTHDC2 to be an endogenous ferroptosis inducer in lung adenocarcinoma. SLC3A2 subunit,SLC3A2 subunit,is essential,CAUSES,for endogenous ferroptosis inducer in lung adenocarcinoma
123, Targeting SLC3A2 subunit of system XC- is essential for m6A reader YTHDC2 to be an endogenous ferroptosis inducer in lung adenocarcinoma. Targeting SLC3A2 subunit,Targeting SLC3A2 subunit,is essential,CAUSES,for to endogenous ferroptosis inducer
123, Targeting SLC3A2 subunit of system XC- is essential for m6A reader YTHDC2 to be an endogenous ferroptosis inducer in lung adenocarcinoma. Targeting SLC3A2 subunit,Targeting SLC3A2 subunit,is essential,CAUSES,for endogenous ferroptosis inducer
123, Targeting SLC3A2 subunit of system XC- is essential for m6A reader YTHDC2 to be an endogenous ferroptosis inducer in lung adenocarcinoma. Targeting SLC3A2 subunit,Targeting SLC3A2 subunit,is essential,CAUSES,to ferroptosis inducer in lung adenocarcinoma
123, Targeting SLC3A2 subunit of system XC- is essential for m6A reader YTHDC2 to be an endogenous ferroptosis inducer in lung adenocarcinoma. Targeting SLC3A2 subunit,Targeting SLC3A2 subunit,is essential,CAUSES,for to ferroptosis inducer
123, Targeting SLC3A2 subunit of system XC- is essential for m6A reader YTHDC2 to be an endogenous ferroptosis inducer in lung adenocarcinoma. SLC3A2 subunit,SLC3A2 subunit,is essential,CAUSES,to ferroptosis inducer
123, Targeting SLC3A2 subunit of system XC- is essential for m6A reader YTHDC2 to be an endogenous ferroptosis inducer in lung adenocarcinoma. SLC3A2 subunit,SLC3A2 subunit,is essential,CAUSES,to endogenous ferroptosis inducer
123, Targeting SLC3A2 subunit of system XC- is essential for m6A reader YTHDC2 to be an endogenous ferroptosis inducer in lung adenocarcinoma. SLC3A2 subunit,SLC3A2 subunit,is essential,CAUSES,for to ferroptosis inducer in lung adenocarcinoma
123, Targeting SLC3A2 subunit of system XC- is essential for m6A reader YTHDC2 to be an endogenous ferroptosis inducer in lung adenocarcinoma. SLC3A2 subunit,SLC3A2 subunit,is essential,CAUSES,to ferroptosis inducer in lung adenocarcinoma
95, N6-methyladenosine Demethylase FTO Induces the Dysfunctions of Ovarian Granulosa Cells by Upregulating Flotillin 2. N6 methyladenosine Demethylase FTO,N6 methyladenosine Demethylase FTO,Induces,CAUSES,Dysfunctions
95, N6-methyladenosine Demethylase FTO Induces the Dysfunctions of Ovarian Granulosa Cells by Upregulating Flotillin 2. N6 methyladenosine Demethylase FTO,N6 methyladenosine Demethylase FTO,Induces,CAUSES,Dysfunctions of Ovarian Granulosa Cells
95, N6-methyladenosine Demethylase FTO Induces the Dysfunctions of Ovarian Granulosa Cells by Upregulating Flotillin 2. N6 methyladenosine Demethylase FTO,N6 methyladenosine Demethylase FTO,Induces,CAUSES,Dysfunctions of Granulosa Cells
166, YTHDF3 Induces the Translation of m6A-Enriched Gene Transcripts to Promote Breast Cancer Brain Metastasis. YTHDF3,YTHDF3,Induces,CAUSES,Translation
166, YTHDF3 Induces the Translation of m6A-Enriched Gene Transcripts to Promote Breast Cancer Brain Metastasis. YTHDF3,YTHDF3,Induces,CAUSES,Translation of Enriched Gene Transcripts
166, YTHDF3 Induces the Translation of m6A-Enriched Gene Transcripts to Promote Breast Cancer Brain Metastasis. YTHDF3,YTHDF3,Induces,CAUSES,Translation of m6A Enriched Gene Transcripts
166, YTHDF3 Induces the Translation of m6A-Enriched Gene Transcripts to Promote Breast Cancer Brain Metastasis. YTHDF3,YTHDF3,Induces,CAUSES,Translation of Gene Transcripts
13, Triclosan-induced abnormal expression of miR-30b regulates fto-mediated m6A methylation level to cause lipid metabolism disorder in zebrafish. m6A methylation level,m6A methylation level,induced expression of,CAUSES,miR 30b
13, Triclosan-induced abnormal expression of miR-30b regulates fto-mediated m6A methylation level to cause lipid metabolism disorder in zebrafish. mediated m6A methylation level,mediated m6A methylation level,induced expression of,CAUSES,miR 30b
23, ALKBH5-modified HMGB1-STING Activation Contributes to Radiation Induced Liver Disease Via Innate Immune Response. HMGB1 STING Activation,HMGB1 STING Activation,Contributes to,CAUSES,Radiation Induced Liver Disease Via Innate Immune Response
23, ALKBH5-modified HMGB1-STING Activation Contributes to Radiation Induced Liver Disease Via Innate Immune Response. modified HMGB1 STING Activation,modified HMGB1 STING Activation,Contributes to,CAUSES,Radiation Induced Liver Disease Via Innate Immune Response
164, N6-Methyladenosine Demethylase FTO Contributes to Neuropathic Pain by Stabilizing G9a Expression in Primary Sensory Neurons. N6 Methyladenosine Demethylase FTO,N6 Methyladenosine Demethylase FTO,Contributes to,CAUSES,Neuropathic Pain
186, YTHDF1 Promotes Cyclin B1 Translation through m6A Modulation and Contributes to the Poor Prognosis of Lung Adenocarcinoma with KRAS/TP53 Co-Mutation. YTHDF1,YTHDF1,Contributes to,CAUSES,Poor Prognosis of Lung Adenocarcinoma with KRAS TP53 Co-Mutation
186, YTHDF1 Promotes Cyclin B1 Translation through m6A Modulation and Contributes to the Poor Prognosis of Lung Adenocarcinoma with KRAS/TP53 Co-Mutation. YTHDF1,YTHDF1,Contributes to,CAUSES,Poor Prognosis of Lung Adenocarcinoma
186, YTHDF1 Promotes Cyclin B1 Translation through m6A Modulation and Contributes to the Poor Prognosis of Lung Adenocarcinoma with KRAS/TP53 Co-Mutation. YTHDF1,YTHDF1,Contributes to,CAUSES,Prognosis
186, YTHDF1 Promotes Cyclin B1 Translation through m6A Modulation and Contributes to the Poor Prognosis of Lung Adenocarcinoma with KRAS/TP53 Co-Mutation. YTHDF1,YTHDF1,Contributes to,CAUSES,Prognosis of Lung Adenocarcinoma
186, YTHDF1 Promotes Cyclin B1 Translation through m6A Modulation and Contributes to the Poor Prognosis of Lung Adenocarcinoma with KRAS/TP53 Co-Mutation. YTHDF1,YTHDF1,Contributes to,CAUSES,Prognosis of Lung Adenocarcinoma with KRAS TP53 Co-Mutation
186, YTHDF1 Promotes Cyclin B1 Translation through m6A Modulation and Contributes to the Poor Prognosis of Lung Adenocarcinoma with KRAS/TP53 Co-Mutation. YTHDF1,YTHDF1,Contributes to,CAUSES,Prognosis with KRAS TP53 Co-Mutation
186, YTHDF1 Promotes Cyclin B1 Translation through m6A Modulation and Contributes to the Poor Prognosis of Lung Adenocarcinoma with KRAS/TP53 Co-Mutation. YTHDF1,YTHDF1,Contributes to,CAUSES,Poor Prognosis with KRAS TP53 Co-Mutation
186, YTHDF1 Promotes Cyclin B1 Translation through m6A Modulation and Contributes to the Poor Prognosis of Lung Adenocarcinoma with KRAS/TP53 Co-Mutation. YTHDF1,YTHDF1,Contributes to,CAUSES,Poor Prognosis
127, Bi-allelic Variants in METTL5 Cause Autosomal-Recessive Intellectual Disability and Microcephaly. Variants,Variants,Cause,CAUSES,Recessive Intellectual Disability
127, Bi-allelic Variants in METTL5 Cause Autosomal-Recessive Intellectual Disability and Microcephaly. Bi-allelic Variants,Bi-allelic Variants,Cause,CAUSES,Disability
127, Bi-allelic Variants in METTL5 Cause Autosomal-Recessive Intellectual Disability and Microcephaly. Bi-allelic Variants,Bi-allelic Variants,Cause,CAUSES,Intellectual Disability
127, Bi-allelic Variants in METTL5 Cause Autosomal-Recessive Intellectual Disability and Microcephaly. Variants,Variants,Cause,CAUSES,Intellectual Disability
127, Bi-allelic Variants in METTL5 Cause Autosomal-Recessive Intellectual Disability and Microcephaly. Bi-allelic Variants,Bi-allelic Variants,Cause,CAUSES,Autosomal Recessive Disability
127, Bi-allelic Variants in METTL5 Cause Autosomal-Recessive Intellectual Disability and Microcephaly. Variants,Variants,Cause,CAUSES,Autosomal Recessive Disability
127, Bi-allelic Variants in METTL5 Cause Autosomal-Recessive Intellectual Disability and Microcephaly. Bi-allelic Variants,Bi-allelic Variants,Cause,CAUSES,Recessive Intellectual Disability
127, Bi-allelic Variants in METTL5 Cause Autosomal-Recessive Intellectual Disability and Microcephaly. Variants,Variants,Cause,CAUSES,Recessive Disability
127, Bi-allelic Variants in METTL5 Cause Autosomal-Recessive Intellectual Disability and Microcephaly. Bi-allelic Variants,Bi-allelic Variants,Cause,CAUSES,Autosomal Recessive Intellectual Disability
127, Bi-allelic Variants in METTL5 Cause Autosomal-Recessive Intellectual Disability and Microcephaly. Bi-allelic Variants,Bi-allelic Variants,Cause,CAUSES,Recessive Disability
127, Bi-allelic Variants in METTL5 Cause Autosomal-Recessive Intellectual Disability and Microcephaly. Variants,Variants,Cause,CAUSES,Autosomal Recessive Intellectual Disability
127, Bi-allelic Variants in METTL5 Cause Autosomal-Recessive Intellectual Disability and Microcephaly. Variants,Variants,Cause,CAUSES,Disability
137, m6A Demethylase FTO Regulates Dopaminergic Neurotransmission Deficits Caused by Arsenite. Dopaminergic Neurotransmission Deficits,Dopaminergic Neurotransmission Deficits,Caused by,CAUSES,Arsenite
131, NSUN2-Mediated m5C Methylation and METTL3/METTL14-Mediated m6A Methylation Cooperatively Enhance p21 Translation. m5C Methylation,m5C Methylation,Cooperatively Enhance,AUGMENTS,p21 Translation
131, NSUN2-Mediated m5C Methylation and METTL3/METTL14-Mediated m6A Methylation Cooperatively Enhance p21 Translation. Mediated m6A Methylation,Mediated m6A Methylation,Cooperatively Enhance,AUGMENTS,p21 Translation
131, NSUN2-Mediated m5C Methylation and METTL3/METTL14-Mediated m6A Methylation Cooperatively Enhance p21 Translation. Mediated m5C Methylation,Mediated m5C Methylation,Cooperatively Enhance,AUGMENTS,p21 Translation
131, NSUN2-Mediated m5C Methylation and METTL3/METTL14-Mediated m6A Methylation Cooperatively Enhance p21 Translation. m6A Methylation,m6A Methylation,Cooperatively Enhance,AUGMENTS,p21 Translation
389, Stabilization of ERK-Phosphorylated METTL3 by USP5 Increases m6A Methylation. Stabilization,Stabilization,Increases,AUGMENTS,m6A Methylation
131, NSUN2-Mediated m5C Methylation and METTL3/METTL14-Mediated m6A Methylation Cooperatively Enhance p21 Translation. Mediated m5C Methylation,Mediated m5C Methylation,Enhance,AUGMENTS,p21 Translation
131, NSUN2-Mediated m5C Methylation and METTL3/METTL14-Mediated m6A Methylation Cooperatively Enhance p21 Translation. Mediated m6A Methylation,Mediated m6A Methylation,Enhance,AUGMENTS,p21 Translation
131, NSUN2-Mediated m5C Methylation and METTL3/METTL14-Mediated m6A Methylation Cooperatively Enhance p21 Translation. m6A Methylation,m6A Methylation,Enhance,AUGMENTS,p21 Translation
131, NSUN2-Mediated m5C Methylation and METTL3/METTL14-Mediated m6A Methylation Cooperatively Enhance p21 Translation. m5C Methylation,m5C Methylation,Enhance,AUGMENTS,p21 Translation
324, RNA Demethylase FTO Mediated RNA m6A Modification Is Involved in Maintaining Maternal-Fetal Interface in Spontaneous Abortion. RNA Demethylase FTO,RNA Demethylase FTO,Mediated,AFFECTS,RNA m6A Modification
122, YTHDF2 promotes mitotic entry and is regulated by cell cycle mediators. YTHDF2,YTHDF2,is regulated by,AFFECTS,cell cycle mediators
218, The m6A Methyltransferase METTL3 Is Functionally Implicated in DLBCL Development by Regulating m6A Modification in PEDF. m6A Methyltransferase METTL3,m6A Methyltransferase METTL3,Is Implicated by,AFFECTS,m6A Modification in PEDF
218, The m6A Methyltransferase METTL3 Is Functionally Implicated in DLBCL Development by Regulating m6A Modification in PEDF. m6A Methyltransferase METTL3,m6A Methyltransferase METTL3,Is Implicated by,AFFECTS,Regulating m6A Modification
218, The m6A Methyltransferase METTL3 Is Functionally Implicated in DLBCL Development by Regulating m6A Modification in PEDF. m6A Methyltransferase METTL3,m6A Methyltransferase METTL3,Is Implicated by,AFFECTS,Regulating m6A Modification in PEDF
218, The m6A Methyltransferase METTL3 Is Functionally Implicated in DLBCL Development by Regulating m6A Modification in PEDF. m6A Methyltransferase METTL3,m6A Methyltransferase METTL3,Is Implicated by,AFFECTS,m6A Modification
135, Early-life m6A RNA demethylation by fat mass and obesity-associated protein (FTO) influences resilience or vulnerability to heat stress later in life. life m6A RNA demethylation,life m6A RNA demethylation,influences later,AFFECTS,resilience
338, Gamete On for m6A: YTHDF2 Exerts Essential Functions in Female Fertility. YTHDF2,YTHDF2,Exerts,AFFECTS,Functions
338, Gamete On for m6A: YTHDF2 Exerts Essential Functions in Female Fertility. YTHDF2,YTHDF2,Exerts,AFFECTS,Essential Functions
413, METTL3 Regulates the m6A Modification of NEK7 to Inhibit the Formation of Osteoarthritis METTL3,METTL3,Regulates,AFFECTS,m6A Modification of NEK7
413, METTL3 Regulates the m6A Modification of NEK7 to Inhibit the Formation of Osteoarthritis METTL3,METTL3,Regulates,AFFECTS,m6A Modification
27, METTL3 Regulates Ossification of the Posterior Longitudinal Ligament via the lncRNA XIST/miR-302a-3p/USP8 Axis. METTL3,METTL3,Regulates,AFFECTS,Ossification of Posterior Ligament
27, METTL3 Regulates Ossification of the Posterior Longitudinal Ligament via the lncRNA XIST/miR-302a-3p/USP8 Axis. METTL3,METTL3,Regulates,AFFECTS,Ossification of Posterior Longitudinal Ligament
27, METTL3 Regulates Ossification of the Posterior Longitudinal Ligament via the lncRNA XIST/miR-302a-3p/USP8 Axis. METTL3,METTL3,Regulates,AFFECTS,Ossification of Ligament
27, METTL3 Regulates Ossification of the Posterior Longitudinal Ligament via the lncRNA XIST/miR-302a-3p/USP8 Axis. METTL3,METTL3,Regulates,AFFECTS,Ossification
27, METTL3 Regulates Ossification of the Posterior Longitudinal Ligament via the lncRNA XIST/miR-302a-3p/USP8 Axis. METTL3,METTL3,Regulates,AFFECTS,Ossification of Longitudinal Ligament
61, METTL3-Mediated m6A Methylation Regulates Muscle Stem Cells and Muscle Regeneration by Notch Signaling Pathway. m6A Methylation,m6A Methylation,Regulates,AFFECTS,Muscle Stem Cells
61, METTL3-Mediated m6A Methylation Regulates Muscle Stem Cells and Muscle Regeneration by Notch Signaling Pathway. Mediated m6A Methylation,Mediated m6A Methylation,Regulates,AFFECTS,Muscle Stem Cells
121, m6A Reader YTHDF2 Regulates LPS-Induced Inflammatory Response. m6A Reader YTHDF2,m6A Reader YTHDF2,Regulates,AFFECTS,LPS Induced Inflammatory Response
133, FTO-Dependent N6-Methyladenosine Regulates Cardiac Function During Remodeling and Repair. N6 Methyladenosine,N6 Methyladenosine,Regulates,AFFECTS,Cardiac Function
133, FTO-Dependent N6-Methyladenosine Regulates Cardiac Function During Remodeling and Repair. N6 Methyladenosine,N6 Methyladenosine,Regulates,AFFECTS,Function
133, FTO-Dependent N6-Methyladenosine Regulates Cardiac Function During Remodeling and Repair. Dependent N6 Methyladenosine,Dependent N6 Methyladenosine,Regulates,AFFECTS,Cardiac Function
133, FTO-Dependent N6-Methyladenosine Regulates Cardiac Function During Remodeling and Repair. Dependent N6 Methyladenosine,Dependent N6 Methyladenosine,Regulates,AFFECTS,Function
137, m6A Demethylase FTO Regulates Dopaminergic Neurotransmission Deficits Caused by Arsenite. m6A Demethylase FTO,m6A Demethylase FTO,Regulates,AFFECTS,Dopaminergic Neurotransmission Deficits Caused
137, m6A Demethylase FTO Regulates Dopaminergic Neurotransmission Deficits Caused by Arsenite. m6A Demethylase FTO,m6A Demethylase FTO,Regulates,AFFECTS,Neurotransmission Deficits Caused by Arsenite
137, m6A Demethylase FTO Regulates Dopaminergic Neurotransmission Deficits Caused by Arsenite. m6A Demethylase FTO,m6A Demethylase FTO,Regulates,AFFECTS,Dopaminergic Neurotransmission Deficits Caused by Arsenite
137, m6A Demethylase FTO Regulates Dopaminergic Neurotransmission Deficits Caused by Arsenite. m6A Demethylase FTO,m6A Demethylase FTO,Regulates,AFFECTS,Neurotransmission Deficits Caused
329, M6A Demethylase ALKBH5 Regulates PD-L1 Expression and Tumor Immunoenvironment in Intrahepatic Cholangiocarcinoma. M6A Demethylase ALKBH5,M6A Demethylase ALKBH5,Regulates,AFFECTS,PD L1 Expression
333, YTHDF1 Regulates Tumorigenicity and Cancer Stem Cell-Like Activity in Human Colorectal Carcinoma. YTHDF1,YTHDF1,Regulates,AFFECTS,Tumorigenicity
333, YTHDF1 Regulates Tumorigenicity and Cancer Stem Cell-Like Activity in Human Colorectal Carcinoma. YTHDF1,YTHDF1,Regulates,AFFECTS,Tumorigenicity in Human Colorectal Carcinoma
388, Ubiquitination Regulates the Proteasomal Degradation and Nuclear Translocation of the Fat Mass and Obesity-Associated (FTO) Protein. Ubiquitination,Ubiquitination,Regulates,AFFECTS,Proteasomal Degradation of Fat Mass Protein
388, Ubiquitination Regulates the Proteasomal Degradation and Nuclear Translocation of the Fat Mass and Obesity-Associated (FTO) Protein. Ubiquitination,Ubiquitination,Regulates,AFFECTS,Degradation
388, Ubiquitination Regulates the Proteasomal Degradation and Nuclear Translocation of the Fat Mass and Obesity-Associated (FTO) Protein. Ubiquitination,Ubiquitination,Regulates,AFFECTS,Proteasomal Degradation
388, Ubiquitination Regulates the Proteasomal Degradation and Nuclear Translocation of the Fat Mass and Obesity-Associated (FTO) Protein. Ubiquitination,Ubiquitination,Regulates,AFFECTS,Degradation of Fat Mass Protein
390, METTL14-Dependent m6A Regulates Vascular Calcification Induced by Indoxyl Sulfate. m6A,m6A,Regulates,AFFECTS,Vascular Calcification Induced
311, The U6 snRNA m6A Methyltransferase METTL16 Regulates SAM Synthetase Intron Retention. U6 snRNA m6A Methyltransferase METTL16,U6 snRNA m6A Methyltransferase METTL16,Regulates,AFFECTS,SAM Synthetase Intron Retention
224, METTL3 Intensifies the Progress of Oral Squamous Cell Carcinoma via Modulating the m6A Amount of PRMT5 and PD-L1. METTL3,METTL3,Modulating,AFFECTS,m6A Amount
224, METTL3 Intensifies the Progress of Oral Squamous Cell Carcinoma via Modulating the m6A Amount of PRMT5 and PD-L1. METTL3,METTL3,Modulating,AFFECTS,m6A Amount of PRMT5
228, RBM15 Modulates the Function of Chromatin Remodeling Factor BAF155 Through RNA Methylation in Developing Cortex. RBM15,RBM15,Modulates,AFFECTS,Function
228, RBM15 Modulates the Function of Chromatin Remodeling Factor BAF155 Through RNA Methylation in Developing Cortex. RBM15,RBM15,Modulates,AFFECTS,Function of Chromatin Remodeling Factor BAF155
336, The m6A-Binding Protein YTHDF1 Mediates Immune Evasion. m6A Binding Protein YTHDF1,m6A Binding Protein YTHDF1,Mediates,AFFECTS,Immune Evasion